Human Aquaporin-3 ELISA: A Key Tool in Aquaporin-3 Detection and Research

Aquaporin-3 (AQP3) is a membrane protein that functions as a water and glycerol channel, playing critical roles in cellular hydration, skin health, and immune responses. The Human Aquaporin-3 ELISA (Enzyme-Linked Immunosorbent Assay) is a specialized tool designed to detect and quantify AQP3 levels in various human biological samples such as serum, plasma, and tissue homogenates. It has become essential in research fields including dermatology, oncology, and immunology.

Key Features of Human Aquaporin-3 ELISA

  1. High Sensitivity and Specificity: The Human Aquaporin-3 ELISA kit is designed to deliver highly specific results, using antibodies that bind exclusively to AQP3. This ensures that the assay accurately detects AQP3 without cross-reactivity with other aquaporins or unrelated proteins. Research on the importance of sensitivity and specificity in ELISAs can be found at NIH.gov and NCBI.
  2. Quantitative Analysis: This ELISA kit allows for the precise quantification of AQP3 levels in biological samples, making it a powerful tool for measuring changes in expression in response to diseases or treatments. For more details on ELISA quantification methods, visit PubMed.
  3. Wide Sample Compatibility: The assay is optimized for various sample types, including serum, plasma, and tissue homogenates, making it adaptable for different research contexts. For instance, tissue samples can provide insights into the role of AQP3 in cancer or skin disorders, while serum or plasma samples are commonly used in immunology studies. You can find protocols for handling different sample types at CDC.gov.
  4. Reproducibility: The Human Aquaporin-3 ELISA is known for its reproducibility, making it suitable for both research and clinical applications. Researchers can rely on consistent data for longitudinal studies or clinical trials, further validating AQP3 as a biomarker. Learn more about reproducibility in ELISAs at FDA.gov.

Applications of Human Aquaporin-3 ELISA in Research

  1. Dermatology: AQP3 is highly expressed in human skin and is essential for skin hydration, elasticity, and barrier function. Dysregulation of AQP3 has been linked to various skin conditions, such as atopic dermatitis and psoriasis. Researchers use the Human AQP3 ELISA to investigate the correlation between AQP3 levels and skin health, particularly in conditions involving impaired skin hydration. You can explore dermatological research involving AQP3 at NCBI.
  2. Cancer Research: Overexpression of AQP3 has been implicated in cancer progression, particularly in colorectal, gastric, and breast cancers. The Human Aquaporin-3 ELISA is a valuable tool for measuring AQP3 expression in tumor tissues, providing insights into how AQP3 contributes to tumor growth, invasion, and metastasis. For studies linking AQP3 to cancer, check out resources at PubMed.
  3. Immune Response and Inflammation: AQP3 has been shown to modulate immune cell function and inflammation, making it a target of interest in autoimmune diseases and inflammatory disorders. The ELISA kit helps quantify AQP3 expression in immune cells or inflammatory tissues, advancing the understanding of its role in immune regulation. Visit NIH.gov for more on AQP3’s involvement in immune function.
  4. Renal Physiology: AQP3 is also expressed in the kidney, where it plays a role in water and glycerol reabsorption. Measuring AQP3 levels using the ELISA assay provides insight into renal function, fluid balance, and disorders like chronic kidney disease or polycystic kidney disease. Renal research involving aquaporins can be accessed via PubMed.

Human Aquaporin-3 ELISA Protocol

  1. Sample Collection: Prepare human serum, plasma, or tissue homogenates following standard procedures. Ensure samples are free from hemolysis and other contaminants that could affect assay results.
  2. Reagent Preparation: Reconstitute all assay reagents and prepare standards according to the kit’s instructions. Dilute samples if necessary to ensure they fall within the assay’s dynamic range.
  3. Assay Procedure: Add the prepared samples and standards to the ELISA plate. Incubate with the anti-AQP3 antibody, followed by the enzyme-conjugated secondary antibody. Wash the plate between each step to remove unbound material.
  4. Detection: Add the substrate solution to initiate the colorimetric reaction. Measure the optical density (OD) using a microplate reader at the recommended wavelength. Quantify AQP3 concentrations by comparing the OD values of samples to those of the standards.
  5. Analysis: Calculate AQP3 concentrations in the samples using a standard curve generated from known concentrations of AQP3. The analysis is typically performed using software that automates standard curve generation and data interpretation.

For detailed ELISA protocols and troubleshooting, consult FDA.gov or visit NCBI for additional guidelines.

Conclusion

The Human Aquaporin-3 ELISA is an essential tool for detecting and quantifying AQP3 levels in various biological samples. It has broad applications in fields such as dermatology, oncology, renal physiology, and immunology. With its high sensitivity, specificity, and reproducibility, this assay offers reliable and quantitative data that contribute to the understanding of AQP3’s role in health and disease.

The CERHR Expert Panel on Bisphenol A accomplished its analysis in August 2007.

ASH sensory neurons are required in Caenorhabditis elegans for a wide range of avoidance behaviors in response to chemical repellents, high osmotic solutions and nose touch. The ASH neurons are therefore hypothesized to be polymodal nociceptive neurons. To understand the nature of polymodal sensory response and adaptation at the cellular level, we expressed the calcium indicator protein cameleon in ASH and analyzed intracellular Ca(2+) responses following stimulation with chemical repellents, osmotic shock and nose touch. We found that a variety of noxious stimuli evoked strong responses in ASH including quinine, denatonium, detergents, heavy metals, both hyper- and hypo-osmotic shock and nose touch. We observed that repeated chemical stimulation led to a reversible reduction in the magnitude of the sensory response, indicating that adaptation occurs within the ASH sensory neuron. A key component of ASH adaptation is GPC-1, a G-protein gamma-subunit expressed specifically in chemosensory neurons. We hypothesize that G-protein gamma-subunit heterogeneity provides a mechanism for repellent-specific adaptation, which could facilitate discrimination of a variety of repellents by these polymodal sensory neurons.

The National Toxicology Program (NTP) Center for the Evaluation of Risks to Human Reproduction (CERHR) carried out an analysis of the potential for bisphenol A to trigger opposed results on copy and growth in people. The CERHR Expert Panel on Bisphenol A accomplished its analysis in August 2007. CERHR chosen bisphenol A for analysis as a result of of the: widespread human publicity; public concern for doable well being results from human exposures; high manufacturing quantity; proof of reproductive and developmental toxicity in laboratory animal research Bisphenol A (CAS RN: 80-05-7) is a high manufacturing quantity chemical used primarily in the manufacturing of polycarbonate plastics and epoxy resins.

Polycarbonate plastics are used in some meals and drink containers; the resins are used as lacquers to coat steel merchandise similar to meals cans, bottle tops, and water provide pipes. To a lesser extent bisphenol A is used in the manufacturing of polyester resins, polysulfone resins, polyacrylate resins, and flame retardants. In addition, bisphenol A is used in the processing of polyvinyl chloride plastic and in the recycling of thermal paper. Some polymers used in dental sealants and tooth coatings comprise bisphenol A. The major supply of publicity to bisphenol A for most individuals is assumed to happen via the food regimen.

While air, mud, and water (including pores and skin contact throughout bathing and swimming) are different doable sources of publicity, bisphenol A in meals and drinks accounts for the majority of each day human publicity. The highest estimated each day intakes of bisphenol A in the common inhabitants happen in infants and youngsters. The outcomes of this bisphenol A analysis are printed in an NTP-CERHR Monograph that consists of the (1) NTP Brief and (2) Expert Panel Report on the Reproductive and Developmental Toxicity of Bisphenol A. Additional info associated to the analysis course of, including the peer overview report for the NTP Brief and public feedback acquired on the draft NTP Brief and the closing knowledgeable panel report.

See bisphenol A below “CERHR Chemicals” on the homepage. The NTP reached the following conclusions on the doable results of publicity to bisphenol A on human growth and copy. Note that the doable ranges of concern, from lowest to highest, are negligible concern, minimal concern, some concern, concern, and critical concern. The NTP has some concern for results on the mind, habits, and prostate gland in fetuses, infants, and youngsters at present human exposures to bisphenol A. The NTP has minimal concern for results on the mammary gland and an earlier age for puberty for females in fetuses, infants, and youngsters at present human exposures to bisphenol A.

The NTP has negligible concern that publicity of pregnant girls to bisphenol A will outcome in fetal or neonatal mortality, beginning defects, or lowered beginning weight and development in their offspring. The NTP has negligible concern that publicity to bisphenol A will trigger reproductive results in non-occupationally uncovered adults and minimal concern for staff uncovered to larger ranges in occupational settings.

Myocardial calcium and magnesium in acute ischemic damage.

The impact of ischemic damage on calcium and magnesium distribution in canine myocardial cells was investigated in tissue broken by occlusion of the circumflex department of the left coronary artery for 60 minutes or for 40 minutes adopted by 20 minutes of reperfusion of the broken tissue by arterial blood. No vital change in the focus of these cations was famous in completely ischemic, irreversibly injured myocardial cells, however tissue calcium was markedly elevated in cells killed by an episode of transient ischemia. Tissue water and sodium additionally have been elevated and magnesium was decreased considerably in the transient ischemia mannequin.

Investigation of the localization of the elevated Ca(–) by cellular fractionation and chemical evaluation in addition to by electron miscroscopy and microincineration confirmed that a lot of it was localized in dense our bodies within the mitochondria. Within the intramitochondrial dense our bodies, the calcium appeared to be a precipitate of an as but undefined kind of calcium phosphate. Dormant Bacillus subtilis spores can be induced to germinate by vitamins, in addition to by nonmetabolizable chemical compounds, similar to a 1:1 chelate of Ca(2+) and dipicolinic acid (DPA).

Nutrients bind receptors in the spore, and this binding triggers occasions in the spore core, including DPA excretion and rehydration, and additionally prompts hydrolysis of the surrounding cortex via mechanisms that are largely unknown. As Ca(2+)-DPA doesn’t require receptors to induce spore germination, we requested if this course of makes use of different proteins, similar to the putative cortex-lytic enzymes SleB and CwlJ, that are concerned in nutrient-induced germination.

ASH sensory neurons are required in Caenorhabditis elegans for a wide range of avoidance behaviors in response to chemical repellents, high osmotic solutions and nose touch. The ASH neurons are therefore hypothesized to be polymodal nociceptive neurons. To understand the nature of polymodal sensory response and adaptation at the cellular level, we expressed the calcium indicator protein cameleon in ASH and analyzed intracellular Ca(2+) responses following stimulation with chemical repellents, osmotic shock and nose touch. We found that a variety of noxious stimuli evoked strong responses in ASH including quinine, denatonium, detergents, heavy metals, both hyper- and hypo-osmotic shock and nose touch. We observed that repeated chemical stimulation led to a reversible reduction in the magnitude of the sensory response, indicating that adaptation occurs within the ASH sensory neuron. A key component of ASH adaptation is GPC-1, a G-protein gamma-subunit expressed specifically in chemosensory neurons. We hypothesize that G-protein gamma-subunit heterogeneity provides a mechanism for repellent-specific adaptation, which could facilitate discrimination of a variety of repellents by these polymodal sensory neurons.

The transient receptor potential channel TRPA1: from gene to pathophysiology.

The Transient Receptor Potential Ankyrin 1 channel (TRPA1), is a member of the massive TRP household of ion channels, and features as a Ca(2+) permeable non-selective cation channel in many alternative cell processes, starting from sensory to homeostatic duties. TRPA1 is extremely conserved throughout the animal kingdom. The solely mammalian TRPA subfamily member, TRPA1, is extensively expressed in neuronal (e.g. sensory dorsal root and trigeminal ganglia neurons)- and in non-neuronal cells (e.g. epithelial cells, hair cells). It reveals 14-19 amino-(N-)terminal ankyrin repeats, an uncommon structural function.

Caspase-2 Fluorometric Assay Kit - 25 assays

GWB-AXR050 25 assays Ask for price

Caspase-9 Fluorometric Assay Kit - 25 assays

GWB-AXR058 25 assays Ask for price

Caspase-5 Fluorometric Assay Kit - 25 assays

GWB-AXR068 25 assays Ask for price

Caspase-4 Fluorometric Assay Kit - 25 assays

GWB-AXR085 25 assays Ask for price

Caspase-10 Fluorometric Assay Kit - 25 assays

GWB-AXR076 25 assays Ask for price

Caspase-6 Fluorometric Assay Kit - 100 assays

GWB-AXR040 100 assays Ask for price

Caspase-6 Fluorometric Assay Kit - 200 assays

GWB-AXR041 200 assays Ask for price

Caspase-6 Fluorometric Assay Kit - 400 assays

GWB-AXR043 400 assays Ask for price

Caspase-3 Fluorometric Assay Kit - 100 assays

GWB-AXR013 100 assays Ask for price

Caspase-3 Fluorometric Assay Kit - 200 assays

GWB-AXR014 200 assays Ask for price

Caspase-3 Fluorometric Assay Kit - 400 assays

GWB-AXR016 400 assays Ask for price

Caspase-1 Fluorometric Assay Kit - 100 assays

GWB-AXR024 100 assays Ask for price

Caspase-1 Fluorometric Assay Kit - 200 assays

GWB-AXR025 200 assays Ask for price

Caspase-1 Fluorometric Assay Kit - 400 assays

GWB-AXR027 400 assays Ask for price

Caspase-8 Fluorometric Assay Kit - 100 assays

GWB-AXR032 100 assays Ask for price

Caspase-8 Fluorometric Assay Kit - 200 assays

GWB-AXR033 200 assays Ask for price

Caspase-8 Fluorometric Assay Kit - 400 assays

GWB-AXR035 400 assays Ask for price

Caspase-2 Fluorometric Assay Kit - 100 assays

GWB-AXR048 100 assays Ask for price

Caspase-2 Fluorometric Assay Kit - 200 assays

GWB-AXR049 200 assays Ask for price

Caspase-2 Fluorometric Assay Kit - 400 assays

GWB-AXR051 400 assays Ask for price

Caspase-9 Fluorometric Assay Kit - 100 assays

GWB-AXR056 100 assays Ask for price

Caspase-9 Fluorometric Assay Kit - 200 assays

GWB-AXR057 200 assays Ask for price

Caspase-9 Fluorometric Assay Kit - 400 assays

GWB-AXR059 400 assays Ask for price

Caspase-5 Fluorometric Assay Kit - 100 assays

GWB-AXR066 100 assays Ask for price

Caspase-5 Fluorometric Assay Kit - 200 assays

GWB-AXR067 200 assays Ask for price

Caspase-5 Fluorometric Assay Kit - 400 assays

GWB-AXR069 400 assays Ask for price

Caspase-4 Fluorometric Assay Kit - 400 assays

GWB-AXR082 400 assays Ask for price

Caspase-4 Fluorometric Assay Kit - 100 assays

GWB-AXR083 100 assays Ask for price

Caspase-4 Fluorometric Assay Kit - 100 assays

GWB-AXR084 100 assays Ask for price

Caspase-10 Fluorometric Assay Kit - 100 assays

GWB-AXR074 100 assays Ask for price

Caspase-10 Fluorometric Assay Kit - 200 assays

GWB-AXR075 200 assays Ask for price

Caspase-10 Fluorometric Assay Kit - 400 assays

GWB-AXR077 400 assays Ask for price

GWB-AXR013-100T - Caspase-3 Fluorometric Assay Kit - 100 assays

GWB-AXR013-100T 100assays
EUR 629

Caspase-8 IETD-R110 Fluorometric and Colorimetric Assay Kit (25 assays)

30011-1 1KIT
EUR 244.8
Description: Minimum order quantity: 1 unit of 1KIT

Caspase-6 Fluorometric Assay Kit

K114-100 each
EUR 516

Caspase-6 Fluorometric Assay Kit

K114-200 each
EUR 738

Caspase-6 Fluorometric Assay Kit

K114-25 each
EUR 242.4

Caspase-6 Fluorometric Assay Kit

K114-400 each
EUR 1149.6

Caspase-6 Fluorometric Assay Kit

K2014-100 100 assays
EUR 322.4
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-6 Fluorometric Assay Kit

K2014-200 200 assays
EUR 492
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-6 Fluorometric Assay Kit

K2014-25 25 assays
EUR 143.2
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-6 Fluorometric Assay Kit

K2014-400 400 assays
EUR 788.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-3 DEVD-R110 Fluorometric and Colorimetric Assay Kit (100 assays)

30008-2 1KIT
EUR 459.6
Description: Minimum order quantity: 1 unit of 1KIT

Caspase-8 IETD-R110 Fluorometric and Colorimetric Assay Kit (100 assays)

30011-2 1KIT
EUR 459.6
Description: Minimum order quantity: 1 unit of 1KIT

Caspase-4 Fluorometric Assay Kit

K126-100 each
EUR 561.6

Caspase-4 Fluorometric Assay Kit

K126-200 each
EUR 738

Caspase-4 Fluorometric Assay Kit

K126-25 each
EUR 255.6

Caspase-4 Fluorometric Assay Kit

K126-400 each
EUR 1110

Caspase-5 Fluorometric Assay Kit

K122-100 each
EUR 523.2

Caspase-5 Fluorometric Assay Kit

K122-200 each
EUR 698.4

Caspase-5 Fluorometric Assay Kit

K122-25 each
EUR 242.4

Caspase-5 Fluorometric Assay Kit

K122-400 each
EUR 1149.6

Caspase-1 Fluorometric Assay Kit

K110-100 each
EUR 574.8

Caspase-1 Fluorometric Assay Kit

K110-200 each
EUR 744

Caspase-1 Fluorometric Assay Kit

K110-25 each
EUR 248.4

Caspase-1 Fluorometric Assay Kit

K110-400 each
EUR 1149.6

Caspase-8 Fluorometric Assay Kit

K112-100 each
EUR 574.8

Caspase-8 Fluorometric Assay Kit

K112-200 each
EUR 738

Caspase-8 Fluorometric Assay Kit

K112-25 each
EUR 248.4

Caspase-8 Fluorometric Assay Kit

K112-400 each
EUR 1149.6

Caspase-2 Fluorometric Assay Kit

K116-100 each
EUR 555.6

Caspase-2 Fluorometric Assay Kit

K116-200 each
EUR 738

Caspase-2 Fluorometric Assay Kit

K116-25 each
EUR 242.4

Caspase-2 Fluorometric Assay Kit

K116-400 each
EUR 1149.6

Caspase-9 Fluorometric Assay Kit

K118-100 each
EUR 561.6

Caspase-9 Fluorometric Assay Kit

K118-200 each
EUR 738

Caspase-9 Fluorometric Assay Kit

K118-25 each
EUR 248.4

Caspase-9 Fluorometric Assay Kit

K118-400 each
EUR 1149.6

Caspase-3 Fluorometric Assay Kit

K2007-100 100 assays
EUR 322.4
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-3 Fluorometric Assay Kit

K2007-200 200 assays
EUR 468.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-3 Fluorometric Assay Kit

K2007-25 25 assays
EUR 143.2
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-3 Fluorometric Assay Kit

K2007-400 400 assays
EUR 788.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-1 Fluorometric Assay Kit

K2010-100 100 assays
EUR 322.4
Description: Cell Biology|Cell Apoptosis

Caspase-1 Fluorometric Assay Kit

K2010-200 200 assays
EUR 468.8
Description: Cell Biology|Cell Apoptosis

Caspase-1 Fluorometric Assay Kit

K2010-25 25 assays
EUR 143.2
Description: Cell Biology|Cell Apoptosis

Caspase-1 Fluorometric Assay Kit

K2010-400 400 assays
EUR 788.8
Description: Cell Biology|Cell Apoptosis

Caspase-8 Fluorometric Assay Kit

K2012-100 100 assays
EUR 322.4
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-8 Fluorometric Assay Kit

K2012-200 200 assays
EUR 492
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-8 Fluorometric Assay Kit

K2012-25 25 assays
EUR 143.2
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-8 Fluorometric Assay Kit

K2012-400 400 assays
EUR 788.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-2 Fluorometric Assay Kit

K2016-100 100 assays
EUR 876.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-2 Fluorometric Assay Kit

K2016-200 200 assays
EUR 835.2

Caspase-2 Fluorometric Assay Kit

K2016-25 25 assays
EUR 285.6

Caspase-2 Fluorometric Assay Kit

K2016-400 400 assays
EUR 1336.8

Caspase-9 Fluorometric Assay Kit

K2018-100 100 assays
EUR 876.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-9 Fluorometric Assay Kit

K2018-200 200 assays
EUR 802.8

Caspase-9 Fluorometric Assay Kit

K2018-25 25 assays
EUR 285.6

Caspase-9 Fluorometric Assay Kit

K2018-400 400 assays
EUR 1336.8

Caspase-3 Fluorometric Assay Kit

K105-100 each
EUR 574.8

Caspase-3 Fluorometric Assay Kit

K105-200 each
EUR 744

Caspase-3 Fluorometric Assay Kit

K105-25 each
EUR 248.4

Caspase-3 Fluorometric Assay Kit

K105-400 each
EUR 1174.8

Caspase-5 Fluorometric Assay Kit

K2195-100 100 assays
EUR 876.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-5 Fluorometric Assay Kit

K2195-200 200 assays
EUR 835.2

Caspase-5 Fluorometric Assay Kit

K2195-25 25 assays
EUR 285.6

Caspase-5 Fluorometric Assay Kit

K2195-400 400 assays
EUR 1336.8

Caspase-4 Fluorometric Assay Kit

K2198-100 100 assays
EUR 864
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-4 Fluorometric Assay Kit

K2198-200 200 assays
EUR 885.6

Caspase-4 Fluorometric Assay Kit

K2198-25 25 assays
EUR 301.2

Caspase-4 Fluorometric Assay Kit

K2198-400 400 assays
EUR 1336.8

Caspase-3 Fluorometric Assay kit

TBS2035 100 tests
EUR 289

Caspase-1 Fluorometric Assay kit

TBS2045 100 tests
EUR 289

Caspase-12 Fluorometric Assay Kit

GWB-AXR105 100 assays Ask for price

Caspase-12 Fluorometric Assay Kit

GWB-AXR106 25 assays Ask for price

Caspase-10 Fluorometric Assay Kit

K124-100 each
EUR 529.2

Caspase-10 Fluorometric Assay Kit

K124-200 each
EUR 738

Caspase-10 Fluorometric Assay Kit

K124-25 each
EUR 242.4

Caspase-10 Fluorometric Assay Kit

K124-400 each
EUR 1149.6

Caspase-12 Fluorometric Assay Kit

K139-100 each
EUR 601.2

Caspase-12 Fluorometric Assay Kit

K139-25 each
EUR 307.2

Caspase-12 Fluorometric Assay Kit

K2150-100 100 assays
EUR 876.8
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Kit#Kits

Caspase-12 Fluorometric Assay Kit

K2150-25 25 assays
EUR 301.2

Genorise® Caspase-6 Fluorometric Assay Kit

GR107024 100 tests
EUR 289

Caspase-Family Fluorometric Assay kit

TBS2055 9x25 tests
EUR 589

Genorise® Caspase-3 Fluorometric Assay Kit

GR107006 100 tests
EUR 350

Genorise® Caspase-1 Fluorometric Assay Kit

GR107008 100 tests
EUR 350

Genorise® Caspase-2 Fluorometric Assay Kit

GR107018 100 tests
EUR 289

Genorise® Caspase-4 Fluorometric Assay Kit

GR107020 100 tests
EUR 289

Genorise® Caspase-5 Fluorometric Assay Kit

GR107022 100 tests
EUR 289

Genorise® Caspase-8 Fluorometric Assay Kit

GR107026 100 tests
EUR 289

Genorise® Caspase-9 Fluorometric Assay Kit

GR107028 100 tests
EUR 289

Genorise® Caspase-10 Fluorometric Assay Kit

GR107030 100 tests
EUR 289

Caspase-8, 10 Activity Fluorometric Assay Kit

RP10238K 1kit
EUR 556.17

Caspase-3, 7 Activity Fluorometric Assay Kit

RP10240K 1kit
EUR 556.17

Caspase-3 Activity Assay Kit II (Fluorometric)

K533-100 each
EUR 614.4

Caspase-3 DEVD-R110 Fluorometric HTS Assay Kit

30009-1 1KIT
EUR 56
Description: N/A

Caspase-3 DEVD-R110 Fluorometric HTS Assay Kit

30009-1-1 KT
EUR 56

Caspase-3 DEVD-R110 Fluorometric HTS Assay Kit

30009-2 1KIT
EUR 199
Description: N/A

Caspase-3 DEVD-R110 Fluorometric HTS Assay Kit

30009-2-1 KT
EUR 199

Caspase-3 DEVD-R110 Fluorometric HTS Assay Kit

30009-3 1KIT
EUR 854
Description: N/A

Caspase-3 DEVD-R110 Fluorometric HTS Assay Kit

30009-3-1 KT
EUR 854

Caspase-8 IETD-R110 Fluorometric HTS Assay Kit

30012-1 1KIT
EUR 120
Description: Minimum order quantity: 1 unit of 1KIT

Caspase-8 IETD-R110 Fluorometric HTS Assay Kit

30012-2 1KIT
EUR 429.6
Description: Minimum order quantity: 1 unit of 1KIT

Caspase-8 IETD-R110 Fluorometric HTS Assay Kit

30012-3 1KIT
EUR 1952.4
Description: Minimum order quantity: 1 unit of 1KIT

Caspae-9 Activity Fluorometric Assay Kit

RP10239K 1kit
EUR 556.17

NADH Fluorometric Assay Kit

K2037-100 100 assays
EUR 857.6
Description: Metabolism Kit|Energy Metabolism Kit#Kits|Metabolism Kit#Kits

HDAC Fluorometric Assay kit

TBS2060 100 tests
EUR 289

Sucrose Fluorometric Assay Kit

E-BC-F042-96T 96T
EUR 350
Description: Quantitative

Sucrose Fluorometric Assay Kit

E-BC-F042-each each Ask for price
Description: Quantitative

Inosine Fluorometric Assay Kit

K712-100 each
EUR 639.6

Lactate Fluorometric Assay Kit

K2140-100 100 assays
EUR 812.8
Description: Metabolism Kit|Energy Metabolism Kit#Kits|Metabolism Kit#Kits

Glucose Fluorometric Assay Kit

K2221-100 100 assays
EUR 819.2
Description: Metabolism Kit|Carbohydrates Kit#Kits|Metabolism Kit#Kits

Sucrose Fluorometric Assay Kit

MBS2567974-5x96Test 5x96Test
EUR 1770

Sucrose Fluorometric Assay Kit

MBS2567974-5x96Tests 5x96Tests
EUR 1770

Sucrose Fluorometric Assay Kit

MBS2567974-96Test 96Test
EUR 390

Sucrose Fluorometric Assay Kit

MBS2567974-96Tests 96Tests
EUR 390

Ethanol Fluorometric Assay kit

TBS2095 100 tests
EUR 259

Glycogen Fluorometric Assay Kit

E-BC-F040-500Assays 500 Assays
EUR 1000
Description: Quantitative

Glycogen Fluorometric Assay Kit

E-BC-F040-96T 96T
EUR 425
Description: Quantitative

Glycogen Fluorometric Assay Kit

E-BC-F040-each each Ask for price
Description: Quantitative

Glycogen Fluorometric Assay Kit

MBS2567972-500Tests 500Tests
EUR 910

Glycogen Fluorometric Assay Kit

MBS2567972-5x100Tests 5x100Tests
EUR 4200

Glycogen Fluorometric Assay Kit

MBS2567972-5x96Test 5x96Test
EUR 2070

Glycogen Fluorometric Assay Kit

MBS2567972-96Test 96Test
EUR 455

Glycogen Fluorometric Assay Kit

MBS2567972-96Tests 96Tests
EUR 455

Glucose-6-Phosphate Fluorometric Assay Kit

K2220-100 100 assays
EUR 832
Description: Metabolism Kit|Energy Metabolism Kit#Kits|Metabolism Kit#Kits

Phosphate Fluorometric Assay Kit

GWB-AXR232 100 assays Ask for price

Fructose-6-Phosphate Fluorometric Assay Kit

K2222-100 100 assays
EUR 716.8
Description: Metabolism Kit|Energy Metabolism Kit#Kits|Metabolism Kit#Kits

Zinc Assay Kit (Fluorometric)

K428-100 each
EUR 627.6

Urea Assay Kit (Fluorometric)

MET-5180 200 assays
EUR 452

Glutathione Fluorometric Assay Kit

K2098-100 100 assays
EUR 825.6
Description: Kits|Metabolism Kit#Metabolism Kit|Oxidative Stress Kit#Kits

Glutathione Fluorometric Assay Kit

K251-100 each
EUR 574.8

The TRPA1 channel is activated by noxious chilly (<17 °C) in addition to by a plethora of chemical compounds that consists of not solely electrophilic compounds and oxidants that can modify, in an alkylative or oxidative vogue, nucleophilic cysteine residues in the channel’s N-terminus, but in addition compounds that don’t covalently bind to the channel proteins (e.g. menthol, nifedipin). Based on localization and purposeful properties, TRPA1 is thought-about a key participant in acute and power (neuropathic) ache and irritation. Moreover, its position in the (patho)physiology of practically all organ methods is anticipated, and will be mentioned alongside with the potential of TRPA1 as a drug goal for the administration of numerous pathological circumstances.

Using chemical shift perturbation to characterise ligand binding.

Using chemical shift perturbation to characterise ligand binding.

Chemical shift perturbation (CSP, chemical shift mapping or complexation-induced modifications in chemical shift, CIS) follows modifications within the chemical shifts of a protein when a ligand is added, and makes use of these to decide the placement of the binding web site, the affinity of the ligand, and/or presumably the construction of the advanced. A key consider figuring out the looks of spectra throughout a titration is the change price between free and certain, or extra particularly the off-rate koff. When koff is bigger than the chemical shift distinction between free and certain, which generally equates to an affinity Kd weaker than about 3μM, then change is quick on the chemical shift timescale.

Under these circumstances, the noticed shift is the population-weighted common of free and certain, which permits Kd to be decided from measurement of peak positions, offered the measurements are made appropriately. (1)H shifts are influenced to a big extent by through-space interactions, whereas (13) and (13)Cβ shifts are influenced extra by through-bond results. (15)N and (13)C’ shifts are influenced each by through-bond and by through-space (hydrogen bonding) interactions. For figuring out the placement of a certain ligand on the idea of shift change, probably the most acceptable methodology is subsequently normally to measure (15)N HSQC spectra, calculate the geometrical distance moved by the height, weighting (15)N shifts by an element of about 0.14 in contrast to (1)H shifts, and choose these residues for which the weighted shift change is bigger than the usual deviation of the shift for all residues.

Other strategies are mentioned, particularly the measurement of (13)CH3 indicators. Slow to intermediate change charges lead to line broadening, and make Kd values very troublesome to acquire. There isn’t any great way to distinguish modifications in chemical shift due to direct binding of the ligand from modifications in chemical shift due to allosteric change. Ligand binding at a number of websites can typically be characterised, by simultaneous becoming of many measured shift modifications, or extra just by including substoichiometric quantities of ligand. The chemical shift modifications can be utilized as restraints for docking ligand onto protein. By use of quantitative calculations of ligand-induced chemical shift modifications, it’s changing into potential to decide not simply the place but in addition the orientation of ligands.

Glutamate and neurotrophic elements in neuronal plasticity and illness.

Glutamate’s position as a neurotransmitter at synapses has been recognized for 40 years, however glutamate has since been proven to regulate neurogenesis, neurite outgrowth, synaptogenesis, and neuron survival within the creating and grownup mammalian nervous system. Cell-surface glutamate receptors are coupled to Ca(2+) inflow and launch from endoplasmic reticulum shops, which causes speedy (kinase- and protease-mediated) and delayed (transcription-dependent) responses that change the construction and performance of neurons. Neurotrophic elements and glutamate work together to regulate developmental and grownup neuroplasticity. For instance, glutamate stimulates the manufacturing of brain-derived neurotrophic issue (BDNF), which, in flip, modifies neuronal glutamate sensitivity, Ca(2+) homeostasis, and plasticity.

Neurotrophic elements could modify glutamate signaling straight, by altering the expression of glutamate receptor subunits and Ca(2+)-regulating proteins, and likewise not directly by inducing the manufacturing of antioxidant enzymes, energy-regulating proteins, and antiapoptotic Bcl-2 relations. Excessive activation of glutamate receptors, beneath situations of oxidative and metabolic stress, could contribute to neuronal dysfunction and degeneration in ailments starting from stroke and Alzheimer’s illness to psychiatric issues. By enhancing neurotrophic issue signaling, environmental elements comparable to train and dietary vitality restriction, and chemical compounds comparable to antidepressants could optimize glutamatergic signaling and shield in opposition to neurological issues.

Using chemical shift perturbation to characterise ligand binding.

Glial cells in (patho)physiology.

Neuroglial cells outline mind homeostasis and mount protection in opposition to pathological insults. Astroglia regulate neurogenesis and improvement of mind circuits. In the grownup mind, astrocytes enter into intimate dynamic relationship with neurons, particularly at synaptic websites the place they functionally kind the tripartite synapse. At these websites, astrocytes regulate ion and neurotransmitter homeostasis, metabolically help neurons and monitor synaptic exercise; one of many readouts of the latter manifests in astrocytic intracellular Ca(2+) indicators. This type of astrocytic excitability can lead to launch of chemical transmitters by way of Ca(2+) -dependent exocytosis.

Once within the extracellular area, gliotransmitters can modulate synaptic plasticity and trigger modifications in habits. Besides these physiological duties, astrocytes are elementary for development and final result of neurological ailments. In Alzheimer’s illness, for instance, astrocytes could contribute to the etiology of this dysfunction. Highly deadly glial-derived tumors use signaling trickery to coerce regular mind cells to help tumor invasiveness. This evaluation not solely sheds new gentle on the mind operation in well being and illness, but in addition factors to many unknowns.

Caspase 1 p10 Antibody

MBS8580369-01mLAF635 0.1mL(AF635)
EUR 465

Caspase-1 (P10) Antibody

ASA-B0283 1 Each Ask for price

Caspase 9 p10 (CASP9 p10) Antibody

abx412368-01mg 0.1 mg
EUR 610.8

Caspase 9 p10 (CASP9 p10) Antibody

abx412368-100g 100 µg
EUR 400

Caspase 14 p10 Antibody

20-abx008233
  • Ask for price
  • Ask for price
  • Ask for price
  • 30 ul
  • 100 ul
  • 200 ul

Caspase 5 p10 Antibody

20-abx009504
  • Ask for price
  • Ask for price
  • Ask for price
  • 30 ul
  • 100 ul
  • 200 ul

Caspase 5 p10 Antibody

E38PA1145 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 14 p10 Antibody

MBS5315521-01mL 0.1mL
EUR 470

Caspase 14 p10 Antibody

MBS5315521-5x01mL 5x0.1mL
EUR 1955

Caspase 5 p10 Antibody

MBS5314084-01mL 0.1mL
EUR 470

Caspase 5 p10 Antibody

MBS5314084-5x01mL 5x0.1mL
EUR 1955

Caspase 5 p10 Antibody

MBS8580379-01mL 0.1mL
EUR 305

Caspase 5 p10 Antibody

MBS8580379-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 5 p10 Antibody

MBS8580379-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 5 p10 Antibody

MBS8580379-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 5 p10 Antibody

MBS8580379-01mLAF635 0.1mL(AF635)
EUR 465

Caspase 5 p10 Antibody

MBS9233174-01mL 0.1mL
EUR 415

Caspase 5 p10 Antibody

MBS9233174-5x01mL 5x0.1mL
EUR 1841

Caspase 5 p10 antibody

70R-49464 100 ul Ask for price

Caspase 14 p10 antibody

70R-50903 100 ul Ask for price

Caspase-3 (P10) Antibody

ASA-B0293 1 Each Ask for price

Caspase-8 (P10) Antibody

ASA-B0304 1 Each Ask for price

Caspase-1 P10 Polyclonal Antibody

BS65859 50ul
EUR 275
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.

Caspase-1 p10 polyclonal antibody

BS5641 50ul
EUR 275
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Caspase-1 P10 Antibody FITC Conjugated

MBS9459788-01mL 0.1mL
EUR 595

Caspase-1 P10 Antibody FITC Conjugated

MBS9459788-5x01mL 5x0.1mL
EUR 2525

Caspase 1 (p10, Cleaved-Ala317) Antibody

20-abx015550
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 100 ug
  • 200 ug
  • 300 µg

Caspase 1 (p10, Cleaved-Ala317) Antibody

E11-0141L 100μg/100μl
EUR 225
Description: Available in various conjugation types.

Caspase 1 (p10, Cleaved-Ala317) Antibody

MBS855006-01mg 0.1mg
EUR 305

Caspase 1 (p10, Cleaved-Ala317) Antibody

MBS855006-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 1 (p10, Cleaved-Ala317) Antibody

MBS855006-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 1 (p10, Cleaved-Ala317) Antibody

MBS855006-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 1 (p10, Cleaved-Ala317) Antibody

MBS855006-01mLAF635 0.1mL(AF635)
EUR 465

caspase-9 p10 (I18) Antibody

MBS440070-02mg 0.2mg
EUR 285

caspase-9 p10 (I18) Antibody

MBS440070-5x02mg 5x0.2mg
EUR 1185

Caspase 14 p10 polyclonal antibody

BS5643 50ul
EUR 275
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Caspase 5 p10 polyclonal antibody

BS5645 50ul
EUR 275
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Polyclonal Anti- Caspase-3 (P10) Antibody

GWB-BBP182 0.1 mg Ask for price

Caspase-1 P10 Polyclonal Antibody Cy5 Conjugated

MBS9459789-01mL 0.1mL
EUR 595

Caspase-1 P10 Polyclonal Antibody Cy5 Conjugated

MBS9459789-5x01mL 5x0.1mL
EUR 2525

Caspase-1 P10 Polyclonal Antibody FITC Conjugated

MBS9463228-01mL 0.1mL
EUR 595

Caspase-1 P10 Polyclonal Antibody FITC Conjugated

MBS9463228-5x01mL 5x0.1mL
EUR 2525

OABB00476-100UG - Caspase-1 (p10) Polyclonal Antibody

OABB00476-100UG 100ug
EUR 419

Caspase 14 (p10, Cleaved-Lys222) Antibody

20-abx015552
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 100 ug
  • 200 ug
  • 300 µg

Caspase 5 (p10, Cleaved-Ser331) Antibody

20-abx015560
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 100 ug
  • 200 ug
  • 300 µg

Caspase 14 (p10, Cleaved-Lys222) Antibody

E11-0148L 100μg/100μl
EUR 225
Description: Available in various conjugation types.

Caspase 4 (p10, Cleaved-Ala290) Antibody

L0480-100ul 100μl
EUR 217
Description: Caspase 4 (p10, Cleaved-Ala290) Rabbit Polyclonal Antibody

Caspase 4 (p10, Cleaved-Ala290) Antibody

L0480-50ul 50μl
EUR 143.5
Description: Caspase 4 (p10, Cleaved-Ala290) Rabbit Polyclonal Antibody

Caspase 14 (p10, Cleaved-Lys222) Antibody

MBS853515-01mg 0.1mg
EUR 305

Caspase 14 (p10, Cleaved-Lys222) Antibody

MBS853515-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 14 (p10, Cleaved-Lys222) Antibody

MBS853515-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 14 (p10, Cleaved-Lys222) Antibody

MBS853515-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 14 (p10, Cleaved-Lys222) Antibody

MBS853515-01mLAF635 0.1mL(AF635)
EUR 465

Caspase 5 (p10,Cleaved-Ser331) Antibody

MBS9508434-005mL 0.05mL
EUR 285

Caspase 5 (p10,Cleaved-Ser331) Antibody

MBS9508434-01mL 0.1mL
EUR 385

Caspase 5 (p10,Cleaved-Ser331) Antibody

MBS9508434-5x01mL 5x0.1mL
EUR 1590

Anti Human Caspase 1 (Casp1) Pab

111658 100 µg Ask for price

Rabbit polyclonal Caspase 1 (p10, Cleaved-Ala317) antibody

TA312624 100 µl Ask for price

Caspase-3(P10)

PA1302 100μg
EUR 260

Caspase-3 (P10)

PA1302-M 100μg
EUR 290
Description: Polyclonal Antibodies Conjugated to Magnetic Beads

Caspase-3 (P10)

PA1302-S 100μg
EUR 290
Description: Polyclonal Antibodies Conjugated to Sepharose Beads

Caspase-3 (P10)

ASA-B0294 1 Each Ask for price

Caspase-1 P10 Rabbit pAb

E47R0169 100ul
EUR 295

Caspase-1 P10 Rabbit pAb

E47R20616 100ul
EUR 295

Caspase-1 P10 Rabbit pAb

E47R20617 100ul
EUR 295

Anti Caspase 3 Pab

165480 100 µg Ask for price

OABB00478-100UG - Caspase-8 (P10) Polyclonal Antibody

OABB00478-100UG 100ug
EUR 419

Caspase 5 Subunit p10 Cleaved-Ser331 (CASP5 p10 Cleaved-S331) Antibody

abx015560-1mg 1 mg
EUR 43.75

Caspase 1 p10 Blocking Peptide

20-abx062325
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

Caspase 1 p10 Blocking Peptide

MBS824336-1mg 1mg
EUR 190

Caspase 1 p10 Blocking Peptide

MBS824336-5mg 5mg
EUR 345

Caspase 1 p10 Blocking Peptide

MBS824336-5x5mg 5x5mg
EUR 1465

Caspase 14 Subunit p10 Cleaved-Lys222 (CASP14 p10 Cleaved-Ks222) Antibody

abx015552-1mg 1 mg
EUR 43.75

Human Caspase 3

117153 100 µg Ask for price

Mouse Caspase 3

117315 100 µg Ask for price

Anti Human Caspase 3 (CASP3) Pab

111287 100 µg Ask for price

Rabbit anti Caspase-9 p10

MBS225062-01mg 0.1mg
EUR 440

Rabbit anti Caspase-9 p10

MBS225062-5x01mg 5x0.1mg
EUR 1805

Rabbit polyclonal Caspase 14 (p10, Cleaved-Lys222) antibody

TA312750 100 µl Ask for price

Anti Myxococcus Xanthus Caspase Pab

272725 100 µg Ask for price

caspase-9 p10 Rabbit pAb

E47R8502 100ul
EUR 295

Caspase 1 Subunit 10 Cleaved-Ala317 (CASP1 p10 Cleaved-A317) Antibody

abx015550-1mg 1 mg
EUR 43.75

Caspase 14 p10 Blocking Peptide

20-abx063778
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

Caspase 5 p10 Blocking Peptide

20-abx062339
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

Caspase 14 p10 Blocking Peptide

MBS823194-1mg 1mg
EUR 190

Caspase 14 p10 Blocking Peptide

MBS823194-5mg 5mg
EUR 345

Caspase 14 p10 Blocking Peptide

MBS823194-5x5mg 5x5mg
EUR 1465

Caspase 5 p10 Blocking Peptide

MBS824429-1mg 1mg
EUR 190

Caspase 5 p10 Blocking Peptide

MBS824429-5mg 5mg
EUR 345

Caspase 5 p10 Blocking Peptide

MBS824429-5x5mg 5x5mg
EUR 1465

Rat Caspase-1 subunit p10 ELISA Kit

E01A12807 96T
EUR 700
Description: ELISA

Rat Caspase-1 subunit p10 ELISA Kit

E02C2773-48wellsplate 48 wells plate
EUR 280

Rat Caspase-1 subunit p10 ELISA Kit

E02C2773-96wellsplate 96 wells plate
EUR 405

Goat Caspase-1 subunit p10 ELISA Kit

E01A47717 96T
EUR 700
Description: ELISA

Goat Caspase-1 subunit p10 ELISA Kit

E06C2773-48wellsplate 48 wells plate
EUR 280

Goat Caspase-1 subunit p10 ELISA Kit

E06C2773-96wellsplate 96 wells plate
EUR 405

Human Caspase-1 subunit p10 ELISA Kit

E01A4044 96T
EUR 700
Description: ELISA

Mouse Caspase-1 subunit p10 ELISA Kit

E01A21548 96T
EUR 700
Description: ELISA

Sheep Caspase-1 subunit p10 ELISA Kit

E01A100011 96T
EUR 700
Description: ELISA

Sheep Caspase-1 subunit p10 ELISA Kit

E14C2773-48wellsplate 48 wells plate
EUR 280

Sheep Caspase-1 subunit p10 ELISA Kit

E14C2773-96wellsplate 96 wells plate
EUR 405

Human Caspase-1 subunit p10 ELISA Kit

E01C2773-48wellsplate 48 wells plate
EUR 280

Human Caspase-1 subunit p10 ELISA Kit

E01C2773-96wellsplate 96 wells plate
EUR 405

Mouse Caspase-1 subunit p10 ELISA Kit

E03C2773-48wellsplate 48 wells plate
EUR 280

Mouse Caspase-1 subunit p10 ELISA Kit

E03C2773-96wellsplate 96 wells plate
EUR 405

Caspase 1 p20 Antibody

20-abx009515
  • Ask for price
  • Ask for price
  • Ask for price
  • 30 ul
  • 100 ul
  • 200 ul

Caspase 1 p20 Antibody

MBS5314073-01mL 0.1mL
EUR 470

Caspase 1 p20 Antibody

MBS5314073-5x01mL 5x0.1mL
EUR 1955

Caspase 1 p20 Antibody

MBS9232498-01mL 0.1mL
EUR 415

Caspase 1 p20 Antibody

MBS9232498-5x01mL 5x0.1mL
EUR 1841

Caspase 1 p20 antibody

70R-49453 100 ul Ask for price

Canine Caspase-1 subunit p10 ELISA Kit

E01A65149 96T
EUR 700
Description: ELISA

Rabbit Caspase-1 subunit p10 ELISA Kit

E01A30285 96T
EUR 700
Description: ELISA

Monkey Caspase-1 subunit p10 ELISA Kit

E01A73863 96T
EUR 700
Description: ELISA

Bovine Caspase-1 subunit p10 ELISA Kit

E01A82582 96T
EUR 700
Description: ELISA

Monkey Caspase-1 subunit p10 ELISA Kit

E09C2773-48wellsplate 48 wells plate
EUR 280

Monkey Caspase-1 subunit p10 ELISA Kit

E09C2773-96wellsplate 96 wells plate
EUR 405

Bovine Caspase-1 subunit p10 ELISA Kit

E11C2773-48wellsplate 48 wells plate
EUR 280

Bovine Caspase-1 subunit p10 ELISA Kit

E11C2773-96wellsplate 96 wells plate
EUR 405

Canine Caspase-1 subunit p10 ELISA Kit

E08C2773-48wellsplate 48 wells plate
EUR 280

Canine Caspase-1 subunit p10 ELISA Kit

E08C2773-96wellsplate 96 wells plate
EUR 405

Rabbit Caspase-1 subunit p10 ELISA Kit

E04C2773-48wellsplate 48 wells plate
EUR 280

Rabbit Caspase-1 subunit p10 ELISA Kit

E04C2773-96wellsplate 96 wells plate
EUR 405

Porcine Caspase-1 subunit p10 ELISA Kit

E01A56434 96T
EUR 700
Description: ELISA

Chicken Caspase-1 subunit p10 ELISA Kit

E01A91304 96T
EUR 700
Description: ELISA

Chicken Caspase-1 subunit p10 ELISA Kit

E12C2773-48wellsplate 48 wells plate
EUR 280

Chicken Caspase-1 subunit p10 ELISA Kit

E12C2773-96wellsplate 96 wells plate
EUR 405

Porcine Caspase-1 subunit p10 ELISA Kit

E07C2773-48wellsplate 48 wells plate
EUR 280

Porcine Caspase-1 subunit p10 ELISA Kit

E07C2773-96wellsplate 96 wells plate
EUR 405

Caspase-1 (P20) Antibody

ASA-B0284 1 Each Ask for price

Caspase-1 (P20) Antibody

ASA-B0285 1 Each Ask for price

CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10)

MBS6013237-01mg 0.1(mg
EUR 630

CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10)

MBS6013237-5x01mg 5x0.1mg
EUR 2680

Cleaved Caspase-1 (Arg317) /P10 Blocking Peptide

AF4022-BP 1mg
EUR 234

caspase-9 p10 (I18) Blocking Peptide

MBS443067-01mg 0.1mg
EUR 160

caspase-9 p10 (I18) Blocking Peptide

MBS443067-5x01mg 5x0.1mg
EUR 625

CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10) (PE)

MBS6156884-01mL 0.1(mL
EUR 875

CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10) (PE)

MBS6156884-5x01mL 5x0.1mL
EUR 3800

CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10) (AP)

MBS6130369-01mL 0.1(mL
EUR 875

CASP14 (Caspase-14, CASP-14, Caspase-14 Subunit p19, Caspase-14 Subunit p10) (AP)

MBS6130369-5x01mL 5x0.1mL
EUR 3800

A brand new program, TALOS-N, is launched for predicting protein spine torsion angles from NMR chemical shifts. The program depends much more extensively on the usage of educated synthetic neural networks than its predecessor, TALOS+. Validation on an impartial set of proteins indicates that spine torsion angles can be predicted for a bigger, ≥90 % fraction of the residues, with an error price smaller than ca 3.5 %, utilizing an acceptance criterion that’s practically two-fold tighter than that used beforehand, and a root imply sq. distinction between predicted and crystallographically noticed (ϕ, ψ) torsion angles of ca 12º. TALOS-N additionally reviews sidechain χ(1) rotameric states for about 50 % of the residues, and a consistency with reference constructions of 89 %.

Interaction of tRNA with 23S rRNA in the ribosomal A, P, and E sites.

Interaction of tRNA with 23S rRNA in the ribosomal A, P, and E sites.

Three units of conserved nucleotides in 23 rRNA are shielded from chemical probes by binding of tRNA to the ribosomal A, P, and E websites, respectively. They are situated nearly solely in area V, primarily in or adjoining to the loop recognized with the peptidyl transferase operate. Some of these websites are additionally protected by antibiotics equivalent to chloramphenicol, which might clarify how these medicine intervene with protein synthesis. Certain tRNA-dependent protections are abolished when the 3′-terminal A or CA or 2′,3′-linked acyl group is eliminated, offering direct proof for the interplay of the conserved CCA terminus of tRNA with 23S rRNA.

When the EF-Tu.GTP.aminoacyl-tRNA ternary advanced is sure to the ribosome, no tRNA-dependent A web site protections are detected in 23S rRNA till EF-Tu is launched. Thus, EF-Tu prevents interplay of the 3′ terminus of the incoming aminoacyl-tRNA with the peptidyl transferase area of the ribosome throughout anticodon choice, thereby allowing translational proofreading. Some PLTS cells appeared to have two axonal origins from the somata and dendrites. LA cells had been principally massive aspiny cells with Ca(2+)-dependent long-lasting afterhyperpolarizations and robust time-dependent hyperpolarizing rectification.

Plants have advanced subtle programs to manage with herbivore challenges. When vegetation understand herbivore-derived bodily and chemical cues, equivalent to elicitors in bugs’ oral secretions and compounds in oviposition fluids, vegetation dramatically reshape their transcriptomes, proteomes, and metabolomes. All these herbivory-induced modifications are mediated by elaborate signaling networks, which embrace receptors/sensors, Ca(2+) influxes, kinase cascades, reactive oxygen species, and phytohormone signaling pathways. Furthermore, herbivory induces protection responses not solely in the wounded areas but additionally in undamaged areas in the attacked leaves and in distal intact (systemic) leaves.

Here, we overview current progress in understanding plant notion of herbivory and oviposition, and the herbivory-induced early signaling occasions and their organic features. We think about the intraspecific phenotypic variety of plant responses to herbivory and focus on the underlying genetic variation. We additionally focus on new instruments and technical challenges in learning plant-herbivore interactions. Our outcomes point out that TRPA1 is an oxidant sensor in sensory neurons, initiating neuronal excitation and subsequent physiological responses in vitro and in vivo.

The impact of cyanide on the efflux of calcium from squid axons.

The common charge fixed for loss of (45)Ca from an unpoisoned squid axon was 1.Eight x 10(-3) min(-1), similar to an efflux of 0.2 p-mole/cm(2) sec.2. The Ca efflux from unpoisoned axons was diminished if exterior calcium was changed with magnesium, or exterior sodium with lithium, choline or dextrose. Replacing each sodium and calcium diminished the efflux to about 40%.3. Cyanide triggered little quick change in Ca efflux however after 1(half of)-2(half of) hr the efflux elevated to 5-15 instances its regular worth. The impact was quickly reversed when cyanide was eliminated.4.

The giant Ca efflux into cyanide was diminished by an element of three when exterior calcium was changed with magnesium and by an extra issue of about six when exterior sodium was changed with lithium.5. The Ca efflux from each poisoned and unpoisoned axons had a Q(10) of 2-3, was not affected by ouabain and was vastly diminished by injecting ethyleneglycol bis (aminoethylether)-N,N’-tetra-acetic acid (EGTA).6. After injecting (45)Ca alongside the axis, the efflux of calcium reached its most rather more quickly in a cyanide-treated axon than in an unpoisoned axon.7. Pre-treatment with cyanide vastly elevated the charge at which calcium was misplaced from axoplasm extruded into flattened dialysis luggage.

The same impact was noticed when cyanide was utilized after extrusion.8. Replacing exterior sodium glutamate with potassium glutamate vastly diminished the loss of (45)Ca from intact axons poisoned with cyanide however had little impact on the loss from extruded axoplasm.9. The charge fixed for loss of the Ca EGTA advanced was about Three x 10(-5) min(-1) for intact axons and 2 x 10(-2) min(-1) for extruded axoplasm.10. A doable clarification of the cyanide impact is that, after poisoning, calcium ions are launched from a retailer and can then change at a better charge with exterior sodium or calcium.11. The experiments counsel that half of the calcium efflux could also be coupled to sodium entry.12. Theoretical equations for ;diffusion and chemical response in a cylinder’ are described in the Appendix.

Interaction of tRNA with 23S rRNA in the ribosomal A, P, and E sites.

TRPA1 is a serious oxidant sensor in murine airway sensory neurons.

Sensory neurons in the airways are finely tuned to answer reactive chemical substances threatening airway operate and integrity. Nasal trigeminal nerve endings are significantly delicate to oxidants shaped in polluted air and throughout oxidative stress in addition to to chlorine, which is steadily launched in industrial and home accidents. Oxidant activation of airway neurons induces respiratory melancholy, nasal obstruction, sneezing, cough, and ache. While usually protecting, chemosensory airway reflexes can provoke extreme issues in sufferers affected by inflammatory airway circumstances like rhinitis and bronchial asthma.

Caspase 9 antibody

22978-100ul 100ul
EUR 468

Caspase 9 Antibody

ABF6348 100 ug
EUR 525.6

Caspase 9 Antibody

21422 100ul
EUR 319

Caspase 9 Antibody

21422-100ul 100ul
EUR 302.4

Caspase 9 Antibody

21422-50ul 50ul
EUR 224.4

Caspase 9 Antibody

DF7048 200ul
EUR 420

Caspase 9 Antibody

DF7048-100ul 100ul
EUR 168
Description: WB,IF/ICC,ELISA(peptide)

Caspase 9 Antibody

DF7048-200ul 200ul
EUR 210
Description: WB,IF/ICC,ELISA(peptide)

Caspase 9 Antibody

AF6348-100ul 100ul
EUR 168
Description: WB,IHC,IF/ICC,ELISA(peptide)

Caspase 9 Antibody

AF6348-200ul 200ul
EUR 210
Description: WB,IHC,IF/ICC,ELISA(peptide)

Caspase 9 Antibody

AF6870-100ul 100ul
EUR 168
Description: ELISA(peptide)

Caspase 9 Antibody

AF6870-200ul 200ul
EUR 210
Description: ELISA(peptide)

Caspase 9 antibody

CAF50061-100ug 100ug
EUR 312

Caspase 9 Antibody

GWB-12726F 0.5 ml Ask for price

Caspase 9 Antibody

E18-6348-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

Caspase 9 Antibody

E18-6348-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

Caspase 9 Antibody

E021422 100μg/100μl
EUR 255
Description: Available in various conjugation types.

Caspase 9 Antibody

E312193 200ul
EUR 275
Description: Available in various conjugation types.

Caspase 9 Antibody

E38PA9134 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 9 Antibody

E38PA1155 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 9 Antibody

E38PA1156 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 9 Antibody

E38PA3157 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 9 Antibody

MBS5316093-01mL 0.1mL
EUR 470

Caspase 9 Antibody

MBS5316093-5x01mL 5x0.1mL
EUR 1955

Caspase 9 Antibody

MBS5312403-01mL 0.1mL
EUR 1070

Caspase 9 Antibody

MBS5312403-5x01mL 5x0.1mL
EUR 4655

Caspase 9 Antibody

MBS5312900-01mg 0.1mg
EUR 975

Caspase 9 Antibody

MBS5312900-5x01mg 5x0.1mg
EUR 4245

Caspase 9 Antibody

MBS5314094-01mL 0.1mL
EUR 470

Caspase 9 Antibody

MBS5314094-5x01mL 5x0.1mL
EUR 1955

Caspase 9 Antibody

MBS5314095-01mL 0.1mL
EUR 470

Caspase 9 Antibody

MBS5314095-5x01mL 5x0.1mL
EUR 1955

Caspase 9 antibody

MBS5309820-005mg 0.05mg
EUR 485

Caspase 9 antibody

MBS5309820-5x005mg 5x0.05mg
EUR 2045

Caspase 9 Antibody

MBS5311183-01mg 0.1mg
EUR 490

Caspase 9 Antibody

MBS5311183-5x01mg 5x0.1mg
EUR 2155

Caspase 9 Antibody

MBS5311295-01mg 0.1mg
EUR 470

Caspase 9 Antibody

MBS5311295-5x01mg 5x0.1mg
EUR 2080

Caspase 9 Antibody

MBS9613891-01mL 0.1mL
EUR 260

Caspase 9 Antibody

MBS9613891-02mL 0.2mL
EUR 305

Caspase 9 Antibody

MBS9613891-5x02mL 5x0.2mL
EUR 1220

Caspase 9 Antibody

MBS8584305-01mL 0.1mL
EUR 305

Caspase 9 Antibody

MBS8584305-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 9 Antibody

MBS8584305-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 9 Antibody

MBS8584305-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 9 Antibody

MBS8584305-01mLAF635 0.1mL(AF635)
EUR 465

Caspase 9 Antibody

MBS9601917-01mL 0.1mL
EUR 260

Caspase 9 Antibody

MBS9601917-02mL 0.2mL
EUR 305

Caspase 9 Antibody

MBS9601917-5x02mL 5x0.2mL
EUR 1220

Caspase 9 Antibody

MBS8581765-01mL 0.1mL
EUR 305

Caspase 9 Antibody

MBS8581765-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 9 Antibody

MBS8581765-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 9 Antibody

MBS8581765-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 9 Antibody

MBS8581765-01mLAF635 0.1mL(AF635)
EUR 465

Caspase 9 Antibody

MBS8580385-01mL 0.1mL
EUR 305

Caspase 9 Antibody

MBS8580385-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 9 Antibody

MBS8580385-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 9 Antibody

MBS8580385-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 9 Antibody

MBS8580385-01mLAF635 0.1mL(AF635)
EUR 465

Caspase 9 Antibody

MBS8580386-01mL 0.1mL
EUR 305

Caspase 9 Antibody

MBS8580386-01mLAF405L 0.1mL(AF405L)
EUR 465

Caspase 9 Antibody

MBS8580386-01mLAF405S 0.1mL(AF405S)
EUR 465

Caspase 9 Antibody

MBS8580386-01mLAF610 0.1mL(AF610)
EUR 465

Caspase 9 Antibody

MBS8580386-01mLAF635 0.1mL(AF635)
EUR 465

Caspase 9 Antibody

MBS8512375-005mg 0.05mg
EUR 235

Caspase 9 Antibody

MBS8512375-01mg 0.1mg
EUR 305

Caspase 9 Antibody

MBS8512375-01mLAF405M 0.1mL(AF405M)
EUR 465

Caspase 9 Antibody

MBS8512375-01mLAF546 0.1mL(AF546)
EUR 465

Caspase 9 Antibody

MBS8512375-01mLAF750 0.1mL(AF750)
EUR 465

Caspase 9 Antibody

MBS856389-01mLAF405L 0.1mL(AF405L)
EUR 565

Caspase 9 Antibody

MBS856389-01mLAF405S 0.1mL(AF405S)
EUR 565

Caspase 9 Antibody

MBS856389-01mLAF610 0.1mL(AF610)
EUR 565

Caspase 9 Antibody

MBS856389-01mLAF635 0.1mL(AF635)
EUR 565

Caspase 9 Antibody

MBS856389-02mL 0.2mL
EUR 345

Caspase 9 Antibody

MBS9406338-005mL 0.05mL
EUR 245

Caspase 9 Antibody

MBS9406338-01mL 0.1mL
EUR 305

Caspase 9 Antibody

MBS9406338-5x01mL 5x0.1mL
EUR 1230

Caspase 9 antibody

MBS9406606-01mL 0.1mL
EUR 420

Caspase 9 antibody

MBS9406606-5x01mL 5x0.1mL
EUR 1740

Caspase 9 Antibody

MBS9503480-005mL 0.05mL
EUR 285

Caspase 9 Antibody

MBS9503480-01mL 0.1mL
EUR 385

Caspase 9 Antibody

MBS9503480-5x01mL 5x0.1mL
EUR 1590

Caspase 9 Antibody

MBS9503800-005mL 0.05mL
EUR 285

Caspase 9 Antibody

MBS9503800-01mL 0.1mL
EUR 385

Caspase 9 Antibody

MBS9503800-5x01mL 5x0.1mL
EUR 1590

Caspase 9 Antibody

MBS9503801-005mL 0.05mL
EUR 285

Caspase 9 Antibody

MBS9503801-01mL 0.1mL
EUR 385

Caspase 9 Antibody

MBS9503801-5x01mL 5x0.1mL
EUR 1590

Caspase 9 Antibody

MBS9503802-005mL 0.05mL
EUR 285

Caspase 9 Antibody

MBS9503802-01mL 0.1mL
EUR 385

Caspase 9 Antibody

MBS9503802-5x01mL 5x0.1mL
EUR 1590

Caspase 9 antibody

20R-1425 100 ug Ask for price

Caspase 9 antibody

70R-49475 100 ul Ask for price

Caspase 9 antibody

70R-33459 100 ug Ask for price

Caspase 9 antibody

70R-11806 100 ug Ask for price

Caspase 9 antibody

70R-33457 100 ug Ask for price

Caspase 9 antibody

70R-51476 100 ul Ask for price

Caspase 9 antibody

20R-2497 50 ug Ask for price

Caspase 9 antibody

20R-1557 100 ug Ask for price

Caspase 9 antibody

70R-13511 100 ul Ask for price

Caspase 9 antibody

70R-31084 100 ug Ask for price

Caspase 9 antibody

70R-33461 100 ug Ask for price

Caspase 9 antibody

70R-30659 100 ug Ask for price

Caspase 9 antibody

70R-11636 100 ug Ask for price

Caspase 9 antibody

70R-14132 100 ug Ask for price

Caspase 9 antibody

70R-31082 100 ug Ask for price

Caspase 9 antibody

70R-31083 100 ug Ask for price

Caspase 9 antibody

70R-49474 100 ul Ask for price

Caspase 9 antibody

20R-1468 100 ug Ask for price

Caspase 9 antibody

20R-1472 100 ug Ask for price

Caspase 9 Antibody

ASA-B0306 1 Each Ask for price

Anti Human Caspase 3 (CASP3) Pab

111287 100 µg Ask for price

Anti Human Caspase 1 (Casp1) Pab

111658 100 µg Ask for price

Caspase-9 Antibody

3409-100 each
EUR 379.2

Caspase-9 Antibody

3409-30T each
EUR 175.2

Caspase-9 Antibody

24049 100ul
EUR 479

Caspase-9 Antibody

24049-100ul 100ul
EUR 468

Caspase-9 Antibody

48161 100ul
EUR 429

Caspase-9 Antibody

48161-100ul 100ul
EUR 399.6

Caspase-9 Antibody

48161-50ul 50ul
EUR 286.8

Caspase-9 Antibody

48687 100ul
EUR 499

Caspase-9 Antibody

48687-100ul 100ul
EUR 399.6

Caspase-9 Antibody

48687-50ul 50ul
EUR 286.8

Caspase-9 Antibody

49014 100ul
EUR 499

Caspase-9 Antibody

49014-100ul 100ul
EUR 399.6

Caspase-9 Antibody

49014-50ul 50ul
EUR 286.8

Caspase-9 Antibody

6670-100 each
EUR 405.6

Caspase-9 Antibody

6670-30T each
EUR 175.2

Caspase-9 Antibody

3136-100 each
EUR 392.4

Caspase-9 Antibody

3136-30T each
EUR 175.2

Caspase-9 Antibody

3016-100 each
EUR 405.6

Caspase-9 Antibody

3016-30T each
EUR 175.2

Caspase-9 Antibody

2071-002mg 0.02 mg
EUR 206.18
Description: Caspase-9 Antibody: Apoptosis is related to many diseases and induced by a family of cell death receptors and their ligands. Cell death signals are transduced by death domain containing adapter molecules and members of the caspase family of proteases. A novel member in the caspase family was recently identified and designated ICE-LAP6, Mch6, and Apaf-3. Caspase-9 and Apaf-1 bind to each other, which leads to caspase-9 activation. Caspase-9 is also activated by granzyme B and CPP32. Activated caspase-9 cleaves and activates caspase-3 that is one of the key proteases, being responsible for the proteolytic cleavage of many key proteins in apoptosis. Caspase-9 play a central role in cell death induced by a wide variety of apoptosis activators including TNFα, TRAIL, anti-CD-95, FADD, and TRADD. Caspase-9 is expressed in a variety of human tissues.

Caspase-9 Antibody

2071-01mg 0.1 mg
EUR 523.7
Description: Caspase-9 Antibody: Apoptosis is related to many diseases and induced by a family of cell death receptors and their ligands. Cell death signals are transduced by death domain containing adapter molecules and members of the caspase family of proteases. A novel member in the caspase family was recently identified and designated ICE-LAP6, Mch6, and Apaf-3. Caspase-9 and Apaf-1 bind to each other, which leads to caspase-9 activation. Caspase-9 is also activated by granzyme B and CPP32. Activated caspase-9 cleaves and activates caspase-3 that is one of the key proteases, being responsible for the proteolytic cleavage of many key proteins in apoptosis. Caspase-9 play a central role in cell death induced by a wide variety of apoptosis activators including TNFα, TRAIL, anti-CD-95, FADD, and TRADD. Caspase-9 is expressed in a variety of human tissues.

Caspase-9 Antibody

2073-002mg 0.02 mg
EUR 206.18
Description: Caspase-9 Antibody: Apoptosis is related to many diseases and induced by a family of cell death receptors and their ligands. Cell death signals are transduced by death domain containing adapter molecules and members of the caspase family of proteases. A novel member in the caspase family was recently identified and designated ICE-LAP6, Mch6, and Apaf-3. Caspase-9 and Apaf-1 bind to each other, which leads to caspase-9 activation. Caspase-9 is also activated by granzyme B and CPP32. Activated caspase-9 cleaves and activates caspase-3 that is one of the key proteases, being responsible for the proteolytic cleavage of many key proteins in apoptosis. Caspase-9 play a central role in cell death induced by a wide variety of apoptosis activators including TNFα, TRAIL, anti-CD-95, FADD, and TRADD. Caspase-9 is expressed in a variety of human tissues.

Caspase-9 Antibody

2073-01mg 0.1 mg
EUR 523.7
Description: Caspase-9 Antibody: Apoptosis is related to many diseases and induced by a family of cell death receptors and their ligands. Cell death signals are transduced by death domain containing adapter molecules and members of the caspase family of proteases. A novel member in the caspase family was recently identified and designated ICE-LAP6, Mch6, and Apaf-3. Caspase-9 and Apaf-1 bind to each other, which leads to caspase-9 activation. Caspase-9 is also activated by granzyme B and CPP32. Activated caspase-9 cleaves and activates caspase-3 that is one of the key proteases, being responsible for the proteolytic cleavage of many key proteins in apoptosis. Caspase-9 play a central role in cell death induced by a wide variety of apoptosis activators including TNFα, TRAIL, anti-CD-95, FADD, and TRADD. Caspase-9 is expressed in a variety of human tissues.

Caspase-9 Antibody

24050 100ul
EUR 479

Caspase-9 Antibody

24050-100ul 100ul
EUR 468

Caspase-9 Antibody

B0060-100ul 100μl
EUR 217
Description: Caspase-9 Rabbit Polyclonal Antibody

Caspase-9 Antibody

B0060-50ul 50μl
EUR 143.5
Description: Caspase-9 Rabbit Polyclonal Antibody

Caspase-9 Antibody

B0832-100ul 100μl
EUR 217
Description: Caspase-9 Rabbit Polyclonal Antibody

Caspase-9 Antibody

B0832-50ul 50μl
EUR 143.5
Description: Caspase-9 Rabbit Polyclonal Antibody

Caspase-9 Antibody

B0833-100ul 100μl
EUR 217
Description: Caspase-9 Rabbit Polyclonal Antibody

Caspase-9 Antibody

B0833-50ul 50μl
EUR 143.5
Description: Caspase-9 Rabbit Polyclonal Antibody

Caspase-9 Antibody

B0834-100ul 100μl
EUR 217
Description: Caspase-9 Rabbit Polyclonal Antibody

Here, we confirmed that each hypochlorite, the oxidizing mediator of chlorine, and hydrogen peroxide, a reactive oxygen species, activated Ca(2+) inflow and membrane currents in an oxidant-sensitive subpopulation of chemosensory neurons. These responses have been absent in neurons from mice missing TRPA1, an ion channel of the transient receptor potential (TRP) gene household. TRPA1 channels have been strongly activated by hypochlorite and hydrogen peroxide in main sensory neurons and heterologous cells. In exams of respiratory operate, Trpa1(-/-) mice displayed profound deficiencies in hypochlorite- and hydrogen peroxide-induced respiratory melancholy in addition to decreased oxidant-induced ache conduct.

Evaluation of the Infinium Methylation 450K technology.

Evaluation of the Infinium Methylation 450K technology.
Studies of DNA methylomes maintain monumental promise for biomedicine however are hampered by the technological challenges of analyzing many samples cost-effectively. Recently, a serious extension of the earlier Infinium HumanMethylation27 BeadChip® (Illumina, Inc. CA, USA), known as Infinium HumanMethylation450 (Infinium Methylation 450Ok; Illumina, Inc. CA, USA) was developed. This upgraded expertise is a hybrid of two totally different chemical assays, the Infinium I and Infinium II assays, permitting (for 12 samples in parallel) evaluation of the methylation standing of greater than 480,000 cytosines distributed over the complete genome.
We used Infinium Methylation 450Ok to profile: first, the well-characterized HCT116 wild-type and double-knockout cell traces after which, 16 breast tissue samples (together with eight regular and eight main tumor samples). Absolute methylation values (β-values) had been extracted with the GenomeStudio™ software program after which subjected to detailed evaluation. In this text, we consider Infinium Methylation 450Ok on cell traces and tissue samples, highlighting some of its benefits but in addition some of its limitations. In explicit, we examine the methylation values of the Infinium I and Infinium II assays.
While this expertise appeared extremely sturdy as beforehand proven, we seen a divergence between the β-values retrieved from the sort I and kind II Infinium assays. Specifically, the β-values obtained from Infinium II probes had been much less correct and reproducible than these obtained from Infinium I probes. This means that information from the sort I and kind II assays must be thought of individually in any downstream bioinformatic evaluation. To have the ability to cope with the Infinium I and Infinium II information collectively, we developed and examined a brand new correction method, which we known as ‘peak-based correction’. The concept was to rescale the Infinium II information on the foundation of the Infinium I information. While this system must be seen as an approximation methodology, it considerably improves the high quality of Infinium II information.
Infinium 450Ok is a strong method in phrases of reagent prices, time of labor, pattern throughput and protection. It holds nice promise for the higher understanding of the epigenetic part in well being and illness. Yet, on account of the nature of its design comprising two totally different chemical assays, evaluation of the complete set of information will not be as straightforward as initially anticipated. Correction methods, reminiscent of the peak-based method proposed right here, are a step in the direction of enough output information evaluation.
Astrocytes set up speedy cell-to-cell communication via the launch of chemical transmitters. The underlying mechanisms and purposeful significance of this launch are, nonetheless, not properly understood. Here we determine an astrocytic vesicular compartment that’s competent for glutamate exocytosis. Using postembedding immunogold labeling of the rat hippocampus, we present that vesicular glutamate transporters (VGLUT1/2) and the vesicular SNARE protein, cellubrevin, are each expressed in small vesicular organelles that resemble synaptic vesicles of glutamatergic terminals.
Evaluation of the Infinium Methylation 450K technology.

Physiological, morphological, and histochemical characterization of three courses of interneurons in rat neostriatum.

Interneurons in lateral half of neostriatum had been studied in remoted slices from juvenile rats (16-20 d postnatal) by whole-cell, current-clamp recording at 33-34 levels C, adopted by intracellular staining with biocytin and double immunocytochemical or histochemical staining for parvalbumin, ChAT, and NADPH diaphorase. Medium-sized spiny neurons (MS cells) had distal dendrites with many spines and had been doubtless projection cells, whereas interneurons had dendrites with fewer spines. The neostriatal interneurons might be additional divided into three courses by physiological, chemical, and morphological standards.

The top notch of interneurons (fast-spiking cells, FS cells) fired very short-duration motion potentials with short-duration afterhyperpolarizations at fixed spike frequency throughout depolarizing present pulses. FS cells had extra destructive resting potentials and decrease enter resistances than the different two courses. At depolarized potentials, FS cells fired repetitive spikes in response to synaptic excitation. FS cells had been immunoreactive for parvalbumin. As all parvalbumin-immunoreactive cells in the neostriatum had been additionally immunoreactive for GABA, FS cells had been thought of to be GABAergic.

FS cells had been additional divided into two morphological varieties: FS cells with native dendritic fields and FS cells with prolonged dendritic fields. The axons of each varieties of FS cells had their densest collateralization inside or close to their dendritic fields. The different two courses of interneuron, PLTS cells (persistent and low-threshold spike cells) and LA cells (long-lasting afterhyperpolarization cells), had been distinguished from FS cells by longer-duration motion potentials and bigger enter resistances, had much less destructive resting potentials, and had longer-lasting afterhyperpolarizations.

CASC3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV632719 1.0 ug DNA
EUR 1626

CASC3 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV632723 1.0 ug DNA
EUR 1626

CASC3 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV632724 1.0 ug DNA
EUR 1626

CASC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV704679 1.0 ug DNA
EUR 540

CASC1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV704683 1.0 ug DNA
EUR 540

CASC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV704684 1.0 ug DNA
EUR 540

CASC4P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV720485 1.0 ug DNA Ask for price

CASC4P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV720489 1.0 ug DNA Ask for price

CASC4P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV720490 1.0 ug DNA Ask for price

CASC3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV632720 1.0 ug DNA
EUR 1626

CASC3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV632721 1.0 ug DNA
EUR 1695.6

CASC3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV632722 1.0 ug DNA
EUR 1695.6

CASC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV704680 1.0 ug DNA
EUR 540

CASC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV704681 1.0 ug DNA
EUR 609.6

CASC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV704682 1.0 ug DNA
EUR 609.6

CASC15 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL318562 5 µg/vial Ask for price

CASC10 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL320065 5 µg/vial Ask for price

CASC4P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV720486 1.0 ug DNA Ask for price

CASC4P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV720487 1.0 ug DNA Ask for price

CASC4P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV720488 1.0 ug DNA Ask for price

Casc1 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL705204 5 µg/vial Ask for price

Casc3 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL713161 5 µg/vial Ask for price

CASC2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL318162 5 µg/vial Ask for price

CASC3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL314191 5 µg/vial Ask for price

Casc3 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL506170 5 µg/vial Ask for price

Casc1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL508351 5 µg/vial Ask for price

CASC1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL305646 5 µg/vial Ask for price

CASC4 ORF Vector (Human) (pORF)

ORF001883 1.0 ug DNA
EUR 114

CASC4 ORF Vector (Human) (pORF)

ORF001884 1.0 ug DNA
EUR 114

Casc4 ORF Vector (Mouse) (pORF)

ORF040409 1.0 ug DNA
EUR 607.2

Casc4 ORF Vector (Mouse) (pORF)

ORF040410 1.0 ug DNA
EUR 607.2

Casc4 ORF Vector (Mouse) (pORF)

ORF040411 1.0 ug DNA
EUR 607.2

Casc4 ORF Vector (Mouse) (pORF)

ORF040412 1.0 ug DNA
EUR 607.2

Casc4 ORF Vector (Mouse) (pORF)

ORF040413 1.0 ug DNA
EUR 607.2

CASC4 Protein Vector (Mouse) (pPM-C-HA)

PV161636 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-HA)

PV161640 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-HA)

PV161644 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-HA)

PV161648 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-HA)

PV161652 500 ng
EUR 723.6

CASC4 Protein Vector (Human) (pPM-C-HA)

PV007531 500 ng
EUR 394.8

CASC4 Protein Vector (Human) (pPM-C-HA)

PV007535 500 ng
EUR 394.8

Cas9 Nickase Lentiviral Vector

K005 10 ug
EUR 135
Description: N/A

CASC4 Protein Vector (Mouse) (pPB-C-His)

PV161634 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-N-His)

PV161635 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-His)

PV161637 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-C-His)

PV161638 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-N-His)

PV161639 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-His)

PV161641 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-C-His)

PV161642 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-N-His)

PV161643 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-His)

PV161645 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-C-His)

PV161646 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-N-His)

PV161647 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-His)

PV161649 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-C-His)

PV161650 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPB-N-His)

PV161651 500 ng
EUR 723.6

CASC4 Protein Vector (Mouse) (pPM-C-His)

PV161653 500 ng
EUR 723.6

CASC4 Protein Vector (Human) (pPB-C-His)

PV007529 500 ng
EUR 394.8

CASC4 Protein Vector (Human) (pPB-N-His)

PV007530 500 ng
EUR 394.8

CASC4 Protein Vector (Human) (pPM-C-His)

PV007532 500 ng
EUR 394.8

CASC4 Protein Vector (Human) (pPB-C-His)

PV007533 500 ng
EUR 394.8

CASC4 Protein Vector (Human) (pPB-N-His)

PV007534 500 ng
EUR 394.8

CASC4 Protein Vector (Human) (pPM-C-His)

PV007536 500 ng
EUR 394.8

Cas9 Nuclease Lentiviral Vector

K002 10 ug
EUR 135
Description: N/A

Casc4 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL508278V 500 ul each Ask for price

CASC4 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL305645V 500 ul each Ask for price

Cas9 Double Mutant Lentiviral Vector

K012 10 ug
EUR 395
Description: N/A

CD Lentiviral Vector

LV678 10 μg
EUR 950

dCas9-KRAB Lentiviral Vector

K203 10 ug
EUR 165
Description: N/A

dCas9-DNMT3A Lentiviral Vector

K091 10 µg, Titer: N/A
EUR 395
Description: N/A

dCas9-TET1CD Lentiviral Vector

K096 10 µg, Titer: N/A
EUR 395
Description: N/A

Green Kit. Baculovirus GFP vector.

K20 1 Kit
EUR 695
Description: Protein expression

ProGreen. Baculovirus GFP marker vector.

A1 25 ul
EUR 420
Description: Protein expression

Protein CASC4 (CASC4) Antibody

abx025754-400l 400 µl
EUR 518.75

Protein CASC4 (CASC4) Antibody

abx025754-400ul 400 ul
EUR 627.6

Protein CASC4 (CASC4) Antibody

abx025754-80l 80 µl
EUR 281.25

CASR Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV699511 1.0 ug DNA
EUR 1626

CASR Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV699515 1.0 ug DNA
EUR 1626

CAST Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV680095 1.0 ug DNA
EUR 1626

CAST Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV680099 1.0 ug DNA
EUR 1626

CAST Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV680125 1.0 ug DNA
EUR 1626

CAST Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV680129 1.0 ug DNA
EUR 1626

CAST Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV680149 1.0 ug DNA
EUR 818.4

CAST Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV680153 1.0 ug DNA
EUR 818.4

CASK Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV676645 1.0 ug DNA
EUR 1626

CASK Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV676649 1.0 ug DNA
EUR 1626

CASP8 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV655159 1.0 ug DNA
EUR 818.4

CASP8 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV655163 1.0 ug DNA
EUR 818.4

CASP7 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV656287 1.0 ug DNA
EUR 616.8

CASP7 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV656291 1.0 ug DNA
EUR 616.8

CASP4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV640789 1.0 ug DNA
EUR 818.4

CASP4 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV640793 1.0 ug DNA
EUR 818.4

CASQ1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV667651 1.0 ug DNA
EUR 818.4

CASQ1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV667655 1.0 ug DNA
EUR 818.4

CASP9 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV668899 1.0 ug DNA
EUR 818.4

CASP9 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV668903 1.0 ug DNA
EUR 818.4

CASP3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV699943 1.0 ug DNA
EUR 616.8

CASP3 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV699947 1.0 ug DNA
EUR 616.8

CASP1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV678997 1.0 ug DNA
EUR 818.4

CASP1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV679001 1.0 ug DNA
EUR 818.4

CASP2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV677605 1.0 ug DNA
EUR 818.4

CASP2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV677609 1.0 ug DNA
EUR 818.4

CASQ2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV667315 1.0 ug DNA
EUR 818.4

CASQ2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV667319 1.0 ug DNA
EUR 818.4

CASR Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV699516 1.0 ug DNA
EUR 1626

CASP12 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV678865 1.0 ug DNA
EUR 818.4

CASP12 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV678869 1.0 ug DNA
EUR 818.4

CAST Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV680100 1.0 ug DNA
EUR 1626

CAST Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV680130 1.0 ug DNA
EUR 1626

CAST Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV680154 1.0 ug DNA
EUR 818.4

CASK Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV676650 1.0 ug DNA
EUR 1626

CASP8 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV655164 1.0 ug DNA
EUR 818.4

CASP7 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV656292 1.0 ug DNA
EUR 616.8

CASP4 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV640794 1.0 ug DNA
EUR 818.4

CASQ1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV667656 1.0 ug DNA
EUR 818.4

CASKIN1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV668263 1.0 ug DNA
EUR 2727.6

CASKIN1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV668267 1.0 ug DNA
EUR 2727.6

CASP9 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV668904 1.0 ug DNA
EUR 818.4

CASP3 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV699948 1.0 ug DNA
EUR 616.8

CASP1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV679002 1.0 ug DNA
EUR 818.4

CASP2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV677610 1.0 ug DNA
EUR 818.4

CASQ2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV667320 1.0 ug DNA
EUR 818.4

CASKP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV758441 1.0 ug DNA Ask for price

CASKP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV758445 1.0 ug DNA Ask for price

CASP12 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV758459 1.0 ug DNA Ask for price

CASP12 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV758463 1.0 ug DNA Ask for price

CASP16 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV758465 1.0 ug DNA Ask for price

CASP16 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV758469 1.0 ug DNA Ask for price

CASP12 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV678870 1.0 ug DNA
EUR 818.4

CASKIN1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV668268 1.0 ug DNA
EUR 2727.6

CASP1P3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV758447 1.0 ug DNA Ask for price

CASP1P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV758451 1.0 ug DNA Ask for price

CASP3P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV758453 1.0 ug DNA Ask for price

CASP3P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV758457 1.0 ug DNA Ask for price

CASP1P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV720497 1.0 ug DNA Ask for price

CASP1P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV720501 1.0 ug DNA Ask for price

CASP1P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV720503 1.0 ug DNA Ask for price

CASP1P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV720507 1.0 ug DNA Ask for price

CASKP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV758446 1.0 ug DNA Ask for price

CASP12 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV758464 1.0 ug DNA Ask for price

CASP16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV758470 1.0 ug DNA Ask for price

Luciferase-mCherry Lentiviral Vector (CMV)

LV010138 1.0 μg
EUR 230

Afterhyperpolarizations of PLTS cells had a shorter time to peak than these of LA cells. PLTS cells fired each Na(+)-dependent, persistent depolarization spikes and Ca(2+)-dependent, low-threshold spikes along with quick spikes. Low-threshold spikes in PLTS cells had been induced solely from hyperpolarized potentials. Both persistent depolarizations and low-threshold spikes may be evoked by synaptic activation. PLTS cells had been histochemically recognized as NADPH diaphorase-positive cells. As all NADPH diaphorase-positive cells in the identical tissue had been immunoreactive for nitric oxide (NO) synthase, PLTS cells had been thought of to launch NO. PLTS cells had the largest axonal fields.

Short-term synaptic plasticity.

Short-term synaptic plasticity.

Synaptic transmission is a dynamic course of. Postsynaptic responses wax and wane as presynaptic exercise evolves. This distinguished attribute of chemical synaptic transmission is an important determinant of the response properties of synapses and, in flip, of the stimulus properties chosen by neural networks and of the patterns of exercise generated by these networks. This evaluation focuses on synaptic modifications that outcome from prior exercise within the synapse below research, and is restricted to short-term results that final for at most a couple of minutes.

Forms of synaptic enhancement, equivalent to facilitation, augmentation, and post-tetanic potentiation, are normally attributed to results of a residual elevation in presynaptic [Ca(2+)]i, appearing on a number of molecular targets that seem like distinct from the secretory set off chargeable for quick exocytosis and phasic launch of transmitter to single motion potentials. We talk about the proof for this speculation, and the origins of the totally different kinetic phases of synaptic enhancement, in addition to the interpretation of statistical modifications in transmitter launch and roles performed by different elements equivalent to alterations in presynaptic Ca(2+) inflow or postsynaptic ranges of [Ca(2+)]i. Synaptic melancholy dominates enhancement at many synapses.

Depression is normally attributed to depletion of some pool of readily releasable vesicles, and numerous types of the depletion mannequin are mentioned. Depression may come up from suggestions activation of presynaptic receptors and from postsynaptic processes equivalent to receptor desensitization. In addition, glial-neuronal interactions can contribute to short-term synaptic plasticity. Finally, we summarize the current literature on putative molecular gamers in synaptic plasticity and the consequences of genetic manipulations and different modulatory influences.

Primary construction of the Aequorea victoria green-fluorescent protein.

Many cnidarians make the most of green-fluorescent proteins (GFPs) as energy-transfer acceptors in bioluminescence. GFPs fluoresce in vivo upon receiving vitality from both a luciferase-oxyluciferin excited-state advanced or a Ca(2+)-activated phosphoprotein. These extremely fluorescent proteins are distinctive because of the chemical nature of their chromophore, which is comprised of modified amino acid (aa) residues throughout the polypeptide. This report describes the cloning and sequencing of each cDNA and genomic clones of GFP from the cnidarian, Aequorea victoria.

The gfp10 cDNA encodes a 238-aa-residue polypeptide with a calculated Mr of 26,888. Comparison of A. victoria GFP genomic clones reveals three totally different restriction enzyme patterns which means that at the least three totally different genes are current within the A. victoria inhabitants at Friday Harbor, Washington. The gfp gene encoded by the lambda GFP2 genomic clone is comprised of at the least three exons unfold over 2.6 kb. The nucleotide sequences of the cDNA and the gene will help within the elucidation of structure-function relationships on this distinctive class of proteins.

Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004. Trends within the RO5 literature explosion that may be discerned are the additional definitions of drug-like. This matter is explored when it comes to drug-like physicochemical options, drug-like structural options, a comparability of drug-like and non-drug-like in drug discovery and a dialogue of how drug-like options relate to medical success. Physicochemical options of CNS medicine and options associated to CNS blood-brain transporter affinity are briefly reviewed. Recent literature on options of non-oral medicine is reviewed and the way options of lead-like compounds differ from these of drug-like compounds is mentioned.

Short-term synaptic plasticity.

In vitro molecular mechanisms of bisphenol A motion.

Bisphenol A (BPA, 2,2-bis (4-hydroxyphenyl) propane; CAS# 80-05-7) is a chemical used primarily within the manufacture of polycarbonate plastic, epoxy resins and as a non-polymer additive to different plastics. Recent proof has demonstrated that human and wildlife populations are uncovered to ranges of BPA which trigger adversarial reproductive and developmental results in various totally different wildlife species and laboratory animal fashions. However, there are main uncertainties surrounding the spectrum of BPA’s mechanisms of motion, the tissue-specific impacts of exposures, and the essential home windows of susceptibility throughout which goal tissues are delicate to BPA exposures.

As a basis to handle a few of these uncertainties, this evaluation was ready by the “In vitro” professional sub-panel assembled in the course of the “Bisphenol A: An Examination of the Relevance of Ecological, In vitro and Laboratory Animal Studies for Assessing Risks to Human Health” workshop held in Chapel Hill, NC, Nov 28-29, 2006. The particular cost of this professional panel was to evaluation and assess the energy of the revealed literature pertaining to the mechanisms of BPA motion. The ensuing doc is an in depth evaluation of revealed research which have centered on the mechanistic foundation of BPA motion in various experimental fashions and an evaluation of the energy of the proof relating to the revealed BPA analysis.

In its present state, the database employs an easy-to-use, searchable interface for acquiring detailed information on the 109 at present recognized RNA modifications. Each entry gives the chemical construction, frequent identify and image, elemental composition and mass, CA registry numbers and index identify, phylogenetic supply, sort of RNA species wherein it’s discovered, and references to the primary reported construction willpower and synthesis. Though newly transferred in its entirety to The RNA Institute, the RNAMDB continues to develop with two notable additions, agmatidine and 8-methyladenosine, appended within the final 12 months.

Anti-CD19-ScFv-CD28-CD3ζ (no marker)

LVP1449 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human CD28 stimulatory domain, do not contain any selection marker.

CAR negative control: Anti-CD19-ScFv- CD28 (Puro)

CAR-ctr4 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: Anti-CD19 (CD28) CAR control lentivirus without activation domain, containing Puromycin selection

Anti-CD19-ScFv-4-1BB-CD3ζ (Bsd)

LVP1441 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing Blasticidin selection

Anti-CD19-ScFv-4-1BB-CD3ζ (Puro)

LVP1440 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing Puromycin selection.

Anti-CD19-ScFv-4-1BB-CD3ζ (no marker)

LVP1444 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, do not contain any selection marker.

Anti-CD19-ScFv-4-1BB-CD3ζ (GFP-Puro)

LVP1442 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing GFP-Puromycin dual selection.

Anti-CD19-ScFv-4-1BB-CD3ζ (RFP-Puro)

LVP1443 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing RFP-Puromycin dual selection.

CAR negative control: Anti-CD19-ScFv-4-1BB (Puro)

CAR-ctr2 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: Anti-CD19 (4-1BB) control lentivirus without activation domain, containing Puromycin selection

Anti-CD19_CD20-ScFv- CD28-CD3ζ (Puro) Lentivirus

LVP1645 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human CD28 stimulatory domain, containing puromycin antibiotic selection

Anti-CD19_CD20-ScFv- CD28-CD3ζ (No Select) Lentivirus

LVP1644 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human CD28 stimulatory domain, do not contain antibiotic selection

Anti-CD19_CD20-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus

LVP1646 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection

PE anti-CD247 (TCRζ, CD3ζ)

GT19033 100 µg Ask for price

PE anti-CD247 (TCRζ, CD3ζ)

GT19032 25 µg Ask for price

FITC anti-CD247 (TCRζ, CD3ζ)

GT19031 100 µg Ask for price

FITC anti-CD247 (TCRζ, CD3ζ)

GT19030 25 µg Ask for price

Anti-CD19_CD20-ScFv-4-1BB-CD3ζ (Puro) Lentivirus

LVP1642 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing puromycin antibiotic selection

Anti-Human CD28 Recombinant Antibody (Anti-CD28)

YR1618
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

Anti-CD19_CD20-ScFv-4-1BB-CD3ζ (No Select) Lentivirus

LVP1641 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, do not contain antibiotic selection

Anti-CD19_CD20-ScFv-4-1BB-CD3ζ (GFP-Puro) Lentivirus

LVP1643 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing GFP-Puromycin dual selection

Anti-CD28 Antibody [CD28.2], PE-25Tests

QAB37-PE-25Tests 25Tests
EUR 169.2

Anti-CD28 Antibody [CD28.2], APC-25Tests

QAB37-APC-25Tests 25Tests
EUR 188.4

Anti-CD28 Antibody [CD28.2], PE-100Tests

QAB37-PE-100Tests 100Tests
EUR 270

Anti-CD28 Antibody [CD28.2], APC-100Tests

QAB37-APC-100Tests 100Tests
EUR 310.8

Anti-CD28 Antibody [CD28.2], FITC-25Tests

QAB37-F-25Tests 25Tests
EUR 157.2

Anti-CD28 Antibody [CD28.2], FITC-100Tests

QAB37-F-100Tests 100Tests
EUR 240

Anti-CD28 Antibody [CD28.2], Qfluor 630-100ug

QAB37-QF630-100ug 100ug
EUR 259.2

Anti-CD28 Antibody [CD28.2], Unconjugated-100ug

QAB37-100ug 100ug
EUR 169.2

Anti-CD28 Antibody [CD28.2], PE-Cy7-25Tests

QAB37-PE7-25Tests 25Tests
EUR 199.2

Anti-CD28 Antibody [CD28.2], PerCP-Cy5.5-100Tests

QAB37-PCP55-100Tests 100Tests
EUR 381.6

Anti-CD28 Antibody [CD28.2], PerCP-Cy5.5-25Tests

QAB37-PCP55-25Tests 25Tests
EUR 229.2

Anti-CD28 Antibody [CD28.2], PE-Cy7-100Tests

QAB37-PE7-100Tests 100Tests
EUR 340.8

Anti-CD3/CD28 stimulus for human PBMC

CT372 50 tests
EUR 141.6

CAR negative control: CD28-CD3ζ (Puro)

CAR-ctr3 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR-T CD28 control lentivirus without targeting domain, containing Puromycin selection

Anti-BCMA-ScFv- CD28-CD3ζ (Puro) Lentivirus

LVP1651 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-BCMA CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-h CD22-ScFv- CD28-CD3ζ (Puro) Lentivirus

LVP1663 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h CD22 CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Hamster Anti CD28 Antibody

20-abx137056
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Anti-h HER2-ScFv- CD28-CD3ζ (Puro) Lentivirus

LVP1657 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HER2 CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-h TGFb-ScFv- CD28-CD3ζ (Puro) Lentivirus

LVP1675 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h TGFb CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-BCMA-ScFv- CD28-CD3ζ (No Select) Lentivirus

LVP1650 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-BCMA CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-BCMA-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus

LVP1652 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-BCMA CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Anti- CD28 Monoclonal Antibody

M00065-1 100ug
EUR 299
Description: Boster Bio Anti- CD28 Monoclonal Antibody catalog # M00065-1. Tested in IHC-P applications. This antibody reacts with Mouse.

Absolute Mcell™ Anti-CD3/CD28 Antibody Magnetic Particles, 5.5 µm, DMF Filed, Sterile

WHM-AB23-095 2.5 mg
EUR 680

Anti-h CD22-ScFv- CD28-CD3ζ (No Select) Lentivirus

LVP1662 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h CD22 CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-CD28

E40YR1618 1 mg
EUR 2960
Description: Available in various conjugation types.

Anti-CD28

MBS156721-01mg 0.1mg
EUR 410

Anti-CD28

MBS156721-1mg 1mg
EUR 1380

Anti-CD28

MBS156721-5x1mg 5x1mg
EUR 5825

anti-CD28

YF-PA10780 50 ug
EUR 435.6
Description: Mouse polyclonal to CD28

Anti-h CD22-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus

LVP1664 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h CD22 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Hamster Anti CD28 FITC Antibody

20-abx137135
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Anti-h HLA-A2-ScFv- CD28-CD3ζ (Puro) Lentivirus

LVP1669 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HLA-A2 CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-h HER2-ScFv- CD28-CD3ζ (No Select) Lentivirus

LVP1656 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HER2 CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-h TGFb-ScFv- CD28-CD3ζ (No Select) Lentivirus

LVP1674 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h TGFb CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-h HER2-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus

LVP1658 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HER2 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Anti-h TGFb-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus

LVP1676 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h TGFb CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Mouse anti CD28 Monoclonal Antibody

MBS460489-01mg 0.1mg
EUR 320

Mouse anti CD28 Monoclonal Antibody

MBS460489-5x01mg 5x0.1mg
EUR 1390

CAR negative control: CD28-CD3ζ (No Select) Lentivirus

CAR-ctr6 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, does not contain any antibiotic selection

CAR negative control: CD28-CD3ζ (GFP-Puro) Lentivirus

CAR-ctr8 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, containing GFP-Puromycin dual selection

Anti-CD28 [1C6]

MBS488426-02mg 0.2mg
EUR 520

Anti-CD28 [1C6]

MBS488426-5x02mg 5x0.2mg
EUR 2160

Hamster Anti CD28 Biotinylated Antibody

20-abx137134
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Anti-CD28 [D665]

MBS488400-02mg 0.2mg
EUR 520

Anti-CD28 [D665]

MBS488400-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [D665]

MBS488401-02mg 0.2mg
EUR 520

Anti-CD28 [D665]

MBS488401-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [JJ316]

MBS488398-02mg 0.2mg
EUR 520

Anti-CD28 [JJ316]

MBS488398-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [JJ316]

MBS488399-02mg 0.2mg
EUR 520

Anti-CD28 [JJ316]

MBS488399-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 Antibody

A00065 0.1mg
EUR 449
Description: Boster Bio Anti-CD28 Antibody (Catalog # A00065). Tested in ELISA, WB, IHC, IF applications. This antibody reacts with Human.

Anti-CD28 Antibody

E38A8582 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Anti-CD28 Antibody

E38A8787 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Anti-CD28 Antibody

ER2001-42 100ul
EUR 189
Description: CD28 (Cluster of Differentiation 28) is one of the proteins expressed on T cells that provide co-stimulatory signals required for T cell activation and survival. T cell stimulation through CD28 in addition to the T-cell receptor (TCR) can provide a potent signal for the production of various interleukins (IL-6 in particular). CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2) proteins. When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen-presenting cells (APCs). The CD86 expression on antigen-presenting cells is constitutive (expression is independent of environmental factors). CD28 is the only B7 receptor constitutively expressed on naive T cells. Association of the TCR of a naive T cell with MHC:antigen complex without CD28:B7 interaction results in a T cell that is anergic.

Anti-CD28 antibody

STJ16100044 100 µg
EUR 424.8

Anti-CD28 antibody

STJ119563 100 µl
EUR 332.4
Description: The protein encoded by this gene is essential for T-cell proliferation and survival, cytokine production, and T-helper type-2 development. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-CD28 antibody

STJ72503 100 µg
EUR 430.8

Anti-CD28 antibody

STJ96609 200 µl
EUR 236.4
Description: Rabbit polyclonal to CD28.

Anti-h HLA-A2-ScFv- CD28-CD3ζ (No Select) Lentivirus

LVP1668 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HLA-A2 CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-h HLA-A2-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus

LVP1670 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HLA-A2 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Goat anti-CD28 Antibody

dAP-2339 50ug
EUR 264.6

Goat anti-CD28 Antibody

MBS422554-01mg 0.1mg
EUR 400

Goat anti-CD28 Antibody

MBS422554-5x01mg 5x0.1mg
EUR 1660

Goat Anti-CD28 Antibody

TA311351 100 µg Ask for price

Goat Anti-Cd28 Antibody

TA311383 100 µg Ask for price

Mouse anti-CD28 Antibody

DL99412A-100ul 100 ul
EUR 299
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Mouse anti-CD28 Antibody

DL99412A-50ul 50 ul
EUR 210
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Anti-Cd28 (mouse) antibody

STJ72504 100 µg
EUR 430.8

Anti-CD300f CD300LF Antibody

A07913 100ul
EUR 399
Description: Boster Bio Anti-CD300f CD300LF Antibody catalog # A07913. Tested in IHC, WB applications. This antibody reacts with Human.

Anti-CD163b CD163L1 Antibody

A09845 100ul
EUR 399
Description: Boster Bio Anti-CD163b CD163L1 Antibody catalog # A09845. Tested in IHC, WB applications. This antibody reacts with Human.

Anti-CD109 antigen CD109 Antibody

A03248 100ul
EUR 380
Description: Boster Bio Anti-CD109 antigen CD109 Antibody catalog # A03248. Tested in ELISA, IHC applications. This antibody reacts with Human.

Anti-CD177 antigen CD177 Antibody

A03958 100ul
EUR 399
Description: Boster Bio Anti-CD177 antigen CD177 Antibody catalog # A03958. Tested in IHC, WB applications. This antibody reacts with Human.

Anti-CD160 antigen CD160 Antibody

A06168-2 100ul
EUR 380
Description: Boster Bio Anti-CD160 antigen CD160 Antibody catalog # A06168-2. Tested in ELISA, IHC, WB applications. This antibody reacts with Human.

Anti-CD320 antigen CD320 Antibody

A06409 100ul
EUR 380
Description: Boster Bio Anti-CD320 antigen CD320 Antibody catalog # A06409. Tested in ELISA, WB applications. This antibody reacts with Human, Mouse, Rat.

Anti-CD16/CD32 [2.4G2]

MBS488077-02mg 0.2mg
EUR 520

Anti-CD16/CD32 [2.4G2]

MBS488077-5x02mg 5x0.2mg
EUR 2160

Anti-CD16/CD32 [2.4G2]

MBS488078-02mg 0.2mg
EUR 520

Anti-CD16/CD32 [2.4G2]

MBS488078-5x02mg 5x0.2mg
EUR 2160

Anti-CD30 / TNFRSF8 Antibody (CD30/412)

A1484-100 each
EUR 574.8

Anti-CD28 [15E8], Mouse IgG1

MBS488979-02mg 0.2mg
EUR 520

Anti-CD28 [15E8], Mouse IgG1

MBS488979-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [15E8], Rabbit IgG

MBS488980-02mg 0.2mg
EUR 520

Anti-CD28 [15E8], Rabbit IgG

MBS488980-5x02mg 5x0.2mg
EUR 2160

Goat anti-Cd28 (mouse) Antibody

dAP-2313 50ug
EUR 264.6

Goat anti-Cd28 (mouse) Antibody

MBS422610-01mg 0.1mg
EUR 400

Goat anti-Cd28 (mouse) Antibody

MBS422610-5x01mg 5x0.1mg
EUR 1660

Anti-CD28 Antibody Picoband™

A00065-3 10ug
EUR 154
Description: Western blot, 0.25-0.5 μg/ml, Human;_x000D_Flow Cytometry, 1-3 μg/1x106 cells, Human;_x000D_Direct ELISA, 0.1-0.5 μg/ml, Human

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal

MBS8101167-01mL 0.1mL
EUR 300

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal

MBS8101167-5x01mL 5x0.1mL
EUR 1200

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal

MBS8101588-01mL 0.1mL
EUR 300

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal

MBS8101588-5x01mL 5x0.1mL
EUR 1200

Rabbit anti-CD28 (pY218) Antibody

DL90184A-100ul 100 ul
EUR 299
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Rabbit anti-CD28 (pY218) Antibody

DL90184A-50ul 50 ul
EUR 209.3
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Rabbit anti-CD28 (pY218) Antibody

YLD1497-100ul 100 ul
EUR 320
Description: Rabbit polyclonal antibody to CD28 (pY218)

Rabbit anti-CD28 (pY218) Antibody

YLD1497-50ul 50 ul
EUR 200
Description: Rabbit polyclonal antibody to CD28 (pY218)

Anti-CD16/CD32 Antibody

E38A8954 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Anti-CD16+CD32 antibody

MO16A(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16A(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody

MO16B(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16B(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody

MO16CFB(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16CFB(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody

MO16F(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16F(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody

MO16F(V500) 500 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PE(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PE(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PP(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PP(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PP5.5(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PP5.5(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PU(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody

MO16PU(V500) 500 ug
EUR 60

Anti-CD28 (pY218) Phospho Antibody

MBS820419-003mL 0.03mL
EUR 195

Anti-CD28 (pY218) Phospho Antibody

MBS820419-01mL 0.1mL
EUR 285

The RNA Modification Database is staying up-to-date with important enhancements being ready for inclusion throughout the subsequent 12 months and the next 12 months. The expanded future position of The RNA Modification Database shall be to function a major info portal for researchers throughout the whole spectrum of RNA-related analysis. Most not too long ago, partly pushed by NIH roadmap initiatives, issues have arisen as to what tool-like means within the seek for chemical instruments to probe biology house.

Crystal structure, chemical bonding and magnetism studies for three quinary polar intermetallic compounds in the (Eu(1-x)Ca(x))9In8(Ge(1-y)Sn(y))8 (x = 0.66, y = 0.03) and the (Eu(1-x)Ca(x))3In(Ge(3-y)Sn(1+y)) (x = 0.66, 0.68; y = 0.13, 0.27) phases.

Crystal structure, chemical bonding and magnetism studies for three quinary polar intermetallic compounds in the (Eu(1-x)Ca(x))9In8(Ge(1-y)Sn(y))8 (x = 0.66, y = 0.03) and the (Eu(1-x)Ca(x))3In(Ge(3-y)Sn(1+y)) (x = 0.66, 0.68; y = 0.13, 0.27) phases.

Three quinary polar intermetallic compounds in the (Eu(1-x)Ca(x))9In8(Ge(1-y)Sn(y))8 (x = 0.66, y = 0.03) and the (Eu(1-x)Ca(x))3In(Ge(3-y)Sn(1+y)) (x = 0.66, 0.68; y = 0.13, 0.27) phases have been synthesized utilizing the molten In-metal flux technique, and the crystal constructions are characterised by powder and single-crystal X-ray diffractions.

Two orthorhombic structural sorts may be seen as an meeting of polyanionic frameworks consisting of the In(Ge/Sn)four tetrahedral chains, the bridging Ge2 dimers, both the annulene-like “12-membered rings” for the (Eu(1-x)Ca(x))9In8(Ge(1-y)Sn(y))Eight sequence or the cis-trans Ge/Sn-chains for the (Eu(1-x)Ca(x))3In(Ge(3-y)Sn(1+y)) sequence, and a number of Eu/Ca-mixed cations.

The most noticeable distinction between two structural sorts is the quantity and the location of the Sn-substitution for Ge: solely a partial substitution (11%) happens at the In(Ge/Sn)four tetrahedron in the (Eu(1-x)Ca(x))9In8(Ge(1-y)Sn(y))Eight sequence, whereas each a whole and a partial substitution (as much as 27%) are noticed, respectively, at the cis-trans Ge/Sn-chain and at the In(Ge/Sn)four tetrahedron in the (Eu(1-x)Ca(x))3In(Ge(3-y)Sn(1+y)) sequence.

A sequence of tight-binding linear muffin-tin orbital calculations is performed to grasp total digital constructions and chemical bonding amongst parts. Magnetic susceptibility measurement signifies a ferromagnetic ordering of Eu atoms beneath 5 Okay for Eu1.02(1)Ca1.98InGe2.87(1)Sn1.13.

Crystal structure, chemical bonding and magnetism studies for three quinary polar intermetallic compounds in the (Eu(1-x)Ca(x))9In8(Ge(1-y)Sn(y))8 (x = 0.66, y = 0.03) and the (Eu(1-x)Ca(x))3In(Ge(3-y)Sn(1+y)) (x = 0.66, 0.68; y = 0.13, 0.27) phases.
Crystal construction, chemical bonding and magnetism studies for three quinary polar intermetallic compounds in the (Eu(1-x)Ca(x))9In8(Ge(1-y)Sn(y))8 (x = 0.66, y = 0.03) and the (Eu(1-x)Ca(x))3In(Ge(3-y)Sn(1+y)) (x = 0.66, 0.68; y = 0.13, 0.27) phases.

Characterization of construction, physico-chemical properties and diffusion conduct of Ca-Alginate gel beads ready by completely different gelation strategies.

Ca-Alginate beads had been ready with both exterior or inside calcium sources by dripping approach. It was discovered that beads synthesized with inside calcium supply had a looser construction and greater pore measurement than these produced with exterior calcium supply.

Consequently, a quicker diffusion charge of Vitamin B12 (VB12) inside the beads with an inside calcium supply was noticed.

Furthermore, the focus of calcium ion, ionic power and pH of the exterior gel beads formation resolution had been investigated. Results confirmed that (a) the focus of the calcium ion was discovered to be the figuring out issue in the gel formation phenomenon; (b) the weight and quantity losses are in impact on account of water elimination; (c) NaCl acts as a competitor with calcium and a display in the electrostatic repulsion; and (d) the pH controls the gel formation course of by regulating the dissociation of alginate and the complexation of the calcium cations.

These outcomes are keys to understanding the conduct and efficiency of beads in their utilization medium.